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Introduction
A half-century ago the humanist Edward M. Brecher reported
a mid-winter epidemic of malaria in Chicago, New York City, St.
Paul, and San Francisco. The epidemic occurred despite the ab-
sence of a single live mosquito, a common carrier of the disease.
Drug-dependent people in these cities were sharing the needles
and syringes they used to inject heroin. If the drug-dependent
person were infected with malaria parasites, his or her needle-
sharing partner ran the risk of acquiring the infection. The epi-
I Brecher, The Case of the Missing Mosquitoes, READER'S DIGEST, Feb. 1941, at 56.
Heroin dealers attempted to impede the needle-borne malaria epidemic by adding quinine
to the heroin "bag" to kill the malaria parasites. Brecher, Needles and the Conscience of
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demic increased the next summer when mosquitoes bit malaria-
infected drug users and transmitted the infection to the wider
public.
Brecher's report demonstrated, as early as 1940, that intra-
venous (IV) drug users could spread an infectious disease to their
needle-sharing partners, and from the partner to other women,
men, and children. 2 Indeed, needle sharing has proven to be an
effective secondary mode of transmission for a diverse range of
blood-borne and sexually transmitted diseases such as bacterial
endocarditis, a  syphilis, 4  hepatitis, 5  cellulitis, 6  and soft-tissue
infections. 7
Needle sharing among drug-dependent people is fueling the
modern human immunodeficiency virus (HIV) epidemic in a pat-
tern strikingly similar to its role in spreading other needle-borne
infections. The transmission of HIV occurs when infected drug
users self-administer heroin, cocaine, 8 amphetamines or other
a Nation, 1 DRUG POL'Y LETTER 5-6 (1989). See also E. BRECHER, LICIT AND ILLICIT
DRUGS (1972).
See Drugs and Ediward Brecher, N.Y. Times, Apr. 25, 1989, at A28, col. 1.
3 Inflammation of the endocardium, or lining membrane of the heart, is caused by the
direct invasion of bacteria and leads to deformity of the valve leaflets. STEDMAN'S MEDICAL
DICTIONARY, 510 (25th ed. 1990) [hereinafter STEDMAN'S].
4 Syphilis is an acute and chronic infectious disease caused by Treponema pallidum
(Spirochaeta pallida) and transmitted by direct contact, usually through sexual intercourse.
The late stages of the disease are marked by formation of gummas and cardiovascular and
central nervous system lesions. STEDMAN'S, supra note 3, at 1544.
5 Hepatitis is an inflammation of the liver. The viral h, type B form of hepatitis is
caused by hepatitis B virus (HBV) (serum hepatitis virus). Necrosis of liver cells is char-
acteristic, and jaundice is a common symptom. STEDMAN'S, supra note 3, at 704-05.
Transmission of HBV sexually and through contaminated needles is the model often used
for HIV. See Blumber & Fox, The Daedalus Effect: Changes in Ethical Questions Relating
to Hepatitis B, 102 ANNALS INTERNAL MED. 390, 394 (1985).
6 Cellulitis is the inflammation of cellular or connective tissue. STEDMAN'S, supra note
3, at 273.
7 See NATIONAL RESEARCH COUNCIL, AIDS: SEXUAL BEHAVIOR AND INTRAVENOUS
DRUG USE 189 (C. Turner, H. Miller & L. Moses eds. 1989) [hereinafter NATIONAL
RESEARCH COUNCIL REPORT].
8 Cocaine affects the HIV epidemic in two significant ways. First, cocaine can be
injected. Indeed, intravenous cocaine users have to inject more frequently than heroin
users to achieve the same high, thus posing a greater risk of transmission of HIV. Currently,
there is no chemical treatment for cocaine use comparable to methadone for heroin use.
For a discussion of methadone maintenance programs, see infra notes 251-253 and accom-
panying text. See also NATIONAL INSTITUTE ON DRUG ABUSE, U.S. DEPARTMENT OF
HEALTH AND HUMAN SERVICES, NIDA MONOGRAPH No. 88, MECHANISMS OF COCAINE
ABUSE AND TOXICITY (1988) [hereinafter NIDA MONOGRAPH No. 88). Second, the ex-
change of sex for cocaine, particularly in crack houses, is fanning the HIV epidemic. See
Fullilove, Thompson, Bowser & Gross, Risk of Sexually Transmitted Disease Among Black
Adolescent Crack Users in Oakland and San Francisco, California, 263 J.A.M.A. 851
(1990). The sexual highs, the payment of money, and the propensity of cocaine users to
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drugs through an injection into a vein, under the skin or into a
muscle ("skin popping"). The needle, syringe and possibly the
"cooker"9 may contain small amounts of HIV-infected blood. To
ensure that no trace of the drug remains in the syringe, the user
often draws his blood into the syringe and reinjects it into his vein,
a practice known as "booting." The "works" are then shared with
another drug-dependent person who draws his own blood into the
syringe, mixing it with the blood from his partner. Thus, the sy-
ringe and needle sharing results in a highly efficient method of
transmitting an infection.10
The needle-borne HIV epidemic is a public health problem of
broad dimensions. Intravenous drug users are the second largest
risk group for HIV infection in the American population. Twenty-
nine percent of all cases of AIDS reported to the U.S. Centers for
Disease Control involve IV drug users."1 The serological preva-
lence of HIV in the IV drug use community is higher still. Epi-
demiological studies in major urban areas, particularly New York,
Northern New Jersey, and Connecticut, demonstrate HIV sero-
prevalence rates of fifty percent or more.12 Moreover, HIV disease
neglect safer sexual practices are all reasons for deep concern about the drug's impact on
the HIV epidemic.
9 A cooker is a spoon or bottle cap used to dissolve the drug in water prior to injection.
10 See Des Jarlais, Friedman & Strug, AIDS and Needle Sharing Within the IV Drug
Use Subculture, in THE SOCIAL DIMENSIONS OF AIDS: METHODS AND THEORY 111 (D.
Feldman & T. Johnson eds. 1986); Ginzburg, Intravenous Drug Abusers and HIV Infection:
A Consequence of Their Actions, 14 LAW, MED. & HEALTH CARE 268 (1986); Stryker, IV
Drug Use and AIDS: Public Policy and Dirty Needles, 14 J. HEALTH POL'Y, POL. & LAW
719 (1989).
" CENTERS FOR DISEASE CONTROL, HIV/AIDS SURVEILLANCE: U.S. CASES REPORTED
THROUGH SEPTEMBER 1990, at 8 (1990) [hereinafter CENTERS FOR DISEASE CONTROL, SEPT.
1990]. Cumulative totals of reported AIDS cases show that 22% were IV drug users and
7% were IV drug users and had had homosexual contact. Indeed, a significant number of
deaths of IV drug abusers may be attributable to HIV disease but are not reported as CDC-
defined AIDS. These deaths may represent a spectrum of HIV-related disease that has not
been identified through AIDS surveillance and has resulted in a large underestimation of
the impact of AIDS on IV drug users, African Americans and Hispanics. Stoneburner, Des
Jarlais, Benezra, Gorelkin, Sotheran, Friedman, Schultz, Marmor, Mildvan & Maslansky,
A Larger Spectrum of Severe HIV-1-Related Disease in Intravenous Drug Users in New
York City, 242 SCIENCE 916 (1988); see NATIONAL RESEARCH CduNCIL REPORT, supra note
7, at 234-37.
12 See Des Jarlais, Friedman & Stoneburner, HIV Infection and Intravenous Drug Use:
Critical Issues in Transmission Dynamics, Infection Outcomes, and Prevention, 10 REV.
OF INFECTIOUS DISEASES 151 (1988); Des Jarlais, Wish, Friedman, Stoneburner, Yancovitz,
Mildvan, EI-Sadr, Brady & Cuadrado, Intravenous Drug Use and the Heterosexual Trans-
mission of the Human Immunodeficiency Virus: Current Trends in New York City, 87 N.Y.
ST. J. MED. 283 (1987); Robertson, Bucknell, Welsby, Roberts, Inglis, Peutherer & Brettle,
Epidemic of AIDS Related Virus (HTLV-IIIILAV) Infection Among Intravenous Drug
Users, 292 BRIT. MED. J. 527, 529 (1986). Needle-borne transmission of HIV, moreover,
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in drug-dependent populations is an epidemic that strikes dispro-
portionately the urban poor, African Americans and Hispanics. 13
Ethnographic studies of this population describe it as "street drug
abusers," the vast majority of whom is homeless, unemployed, or
underemployed. Many also suffer from multiple physical depen-
dencies on drugs and alcohol.14 These studies point to the vulner-
ability of the drug-dependent population and its frequent inability
to meet its own health care needs.
HIV among IV drug users is also the single most important
source for the spread of the infection to non-risk groups. It is likely
that if heterosexual transmission of HIV becomes self-sustaining,
IV drug users will be the source of infection. 15 Nearly seventy-
two percent of all heterosexual cases of AIDS reported in the
United States involve persons who have had sexual contact with
an IV drug user. 16 The connection between pediatric AIDS and IV
drug use is even more striking. Seventy-nine percent of all children
born infected with HIV have a mother who either was an IV drug
user or had sexual relations with an IV drug user. 17
is an international phenomenon with comparably high rates of AIDS and HIV infection
among IV drug users in parts of Europe. Approximately 18% of reported cases of AIDS in
Europe indicate IV drug use as a risk factor (3% of these cases also had homosexual
contacts). The percentage of people with AIDS who are IV drug users is significantly higher
in certain countries. For example, in Italy and Spain, IV drug users account for 65% and
59% of adult cases of AIDS, respectively. WORLD HEALTH ORGANIZATION, PROGRESS
REPORT No. 4, 8, GLOBAL PROGRAMME ON AIDS (1988); see Angrarano, Pastore, Monno,
Santantonio, Luchena & Schiraldi, Rapid Spread of HTLV-1II Infection Among Drug
Addicts in Italy, 2 LANCET 1302 (1985).
'3 Over 43% of all cases of AIDS reported to the CDC involve African Americans
(28%) or Hispanics (nearly 16%). CENTERS FOR DISEASE CONTROL, SEPT. 1990, supra note
11, at 12; see also Des Jarlais & Friedman, HIV Infection Among Persons Who Inject Illicit
Drugs: Problems and Prospects, I J. ACQUIRED IMMUNE DEFICIENCY SYNDROME 267, 269
(1988) (higher HIV seroprevalence among ethnic minority drug users). The risk factors are
related to behavior, but not race. "To label a pigment as a risk factor is to promote...
racist notions that have hampered HIV research, thwarted access to care, and tainted
educational efforts about HIV:" Dawson, HIV in Intravenous Drug Users, 322 NEw ENG.
J. MED. 632 (1990).
14 Feldman & Biernacki, The Ethnography of Needle Sharing Among Intravenous Drug
Users and Implications for Public Policies and Intervention Strategies, in NATIONAL
INSTITUTE ON DRUG ABUSE, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, NIDA
MONOGRAPH No. 80, NEEDLE SHARING AMONG INTRAVENOUS DRUG ABUSERS: NATIONAL
AND INTERNATIONAL PERSPECTIVES 28 (1988) [hereinafter NIDA MONOGRAPH No. 80].
i5 NATIONAL RESEARCH COUNCIL REPORT, supra note 7, at 2186.
16 CENTERS FOR DISEASE CONTROL 1990, supra note 11, at 9. This figure excludes
females born outside the United States in Pattern II countries, where heterosexual trans-
mission patterns are more evident. In New York City almost 90% of the heterosexual
transmission cases of AIDS involve sexual relations with an IV drug user. Des Jarlais &
Friedman, The Psychology of Preventing AIDS Among Intravenous Drug Users, 43 AM.
PSYCHOLOGIST 865 (1988).
'7 CENTERS FOR DISEASE CONTROL, SEPT. 1990, supra note 11, at 9. This figure
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Drug dependence and HIV are America's two most pressing
epidemics, 8 interconnected by a cycle of urban poverty, physical
dependence and a culture of sharing needles and syringes. 9 Extant
political strategies to curb these interconnected epidemics involve
two traditional approaches. The first-law enforcement and in-
terdiction-is designed to limit the supply of illicit drugs to the
marketplace. This strategy is advanced by broad criminal sanctions
against importing, selling, distributing, medically prescribing, or
possessing illicit drugs or drug paraphernalia. The second strategy
to combat the drug and HIV epidemics involves reducing the
demand for illicit drugs. Education, counseling, and treatment
(detoxification, maintenance, and rehabilitation) are all designed
to reduce dependence on drugs, and are called demand-side poli-
cies. For those who cannot stop drug use, public health strategies
seek to alter dangerous sharing behavior or to encourage the ster-
ilization of works.
Supply-side and demand-side policies are often in conflict,
and this conflict reduces the efficiency of the programs and thwarts
the public health goals that underlie both types of policies. For
example, counseling, education, and outreach programs designed
to teach drug-dependent people safer ways to engage in unlawful
behaviors appear to condone or even foster drug use. Drug users
who follow public health advice and carry clean injection equip-
ment or bleach to sterilize that equipment may provide law en-
forcement personnel with evidence of criminal behavior. Similarly,
ex-addicts hired by public health departments to distribute drug-
injection equipment in shooting galleries come close to aiding and
abetting the commission of a crime. Finally, needle and syringe
exchange programs require the distribution of equipment with the
knowledge that it will be used to inject drugs. Such acts are spe-
cifically prohibited under present drug-paraphernalia statutes.
The conflict between supply-side and demand-side policies is
also reflected in the relative funding that the federal government
commits to law enforcement and public health. Less than two
excludes females born in Pattern II countries where heterosexual transmission patterns are
more evident.
"s See generally NATIONAL RESEARCH COUNCIL REPORT, supra note 7; REPORT OF
THE PRESIDENTIAL COMMISSION ON THE HUMAN IMMUNODEFICIENCY VIRUS EPIDEMIC
94-104 (1988) [hereinafter REPORT OF THE PRESIDENTIAL COMMISSION]; Schuster, A Fed-
eral Agency Perspective on AIDS, 43 AM. PSYCHOLOGIST 846, 848 (1988).
'9 See Three Plagues, N.Y. Times, Feb. 23, 1989, at A22, col. 1.
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decades ago only 44.1% of the federal drug abuse budget went to
activities related to interdiction, eradication and other law enforce-
ment, with the remaining funds going to drug treatment, preven-
tion, and education. By 1976 the proportion was still relatively
even with 50.4% going to law enforcement. In the last decade,
however, expenditures for law enforcement rose substantially to
between 73% and 82% of the drug abuse budget.20 The increase in
the enforcement budget reflects the current government philoso-
phy that strong supply-side efforts that emphasize the criminal and
immoral aspects of drug use will yield health benefits for the public.
The uniting theme of this Article is that government should
pursue a consistent policy on drug use that explicitly prefers ther-
apeutic and public health goals to law enforcement goals when
these two are in conflict.21 Such a preference for therapeutic goals
is needed because of the seriousness of the HIV epidemic and
because the sweep of criminal prohibitions and government regu-
lation often renders public health measures ineffective. 22 A pref-
erence for public health over law enforcement is justified on both
conceptual and empirical grounds.23 The raison d'Jtre of the sup-
ply-side policies is to protect the health of the user and of the
public. Thus the human tragedy of the drug and HIV epidemics is
not simply that people are acting unlawfully or immorally, but that
drug dependency is destructive to a person's health and to the
health of the community. The goal of supply-side policies should
be to protect the health and safety of the individual and the com-
munity, not simply to punish "immoral, self-gratifying" behavior.
Thus, the measure of effectiveness of those policies should be
whether they succeed in lowering rates of drug dependency and
20 Brecher, Needles and the Conscience of a Nation, supra note 1, at 5-6; see infra
notes 276-282 and accompanying text.
21 Some European countries have explicitly affirmed the importance of public health
over law enforcement as a strategy for confronting the needle-borne HIV epidemic. See
Fox, Day & Klein, The Power of Professionalism: Policies for AIDS in Britain, Sweden,
and the United States, 118 DAEDALUS 93 (1989).
2 Supply-side policies appropriately criminalize the importation and sale of illicit drugs,
but they go further to impose criminal sanctions on people who are physically dependent
on drugs. To be sure, the Constitution prohibits the criminal law from penalizing a person
for the status of drug dependency. Robinson v. California, 370 U.S. 660 (1962). But penalties
for simple possession of drugs or even drug paraphernalia go as far as is constitutionally
permissible to impose criminal sanctions on individuals as a direct result of their medical
illness.
23 See Gostin, An Alternative Public Health Vision for a National Drug Strategy:
"Treatment Works", 28 U. Hous. L. REv. (forthcoming 1991).
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needle-borne transmission of infection. If supply-side policies fail
this test, they defeat the very objective for which they were for-
mulated and lose their validity.
The nation's law enforcement strategy to curb the drug de-
pendency and HIV epidemics has not been successful. The rate
of serious drug use and the needle-borne spread of HIV are both
growing in ways that are profoundly detrimental to the health of
the public. 24 The United States has not attempted a comprehensive
public health approach to confront the dual epidemics of drugs
and HIV. Yet, as this Article will demonstrate, scientific studies
show that public health policies will be effective in reducing the
demand for drugs, the sharing of drug-injection equipment, and
the overall risk of HIV infection. Consistent with these studies
and with a focus on demand-side policies, this Article presents
three strategies for controlling the spread of HIV in the drug-
dependent population.
The first public health strategy is to prevent the sharing of
drug-injection equipment. Sharing could be prevented through the
creation or expansion of education, counseling, and outreach pro-
grams. Highly disparate HIV prevalence rates exist among IV drug
populations in the United States and abroad. The risk of HIV
transmission does not exist if drug-dependent people use and re-
use their own needles and syringes. Accordingly, the first strategy
for breaking the cycle of HIV infection among drug-dependent
people is to prevent the sharing of works.
The second public health strategy is to ensure that drug-de-
pendent people use sterile injection equipment. Drug-dependent
people can obtain access to safe injection equipment by sterilizing
it themselves, by purchasing it over the counter, or by receiving
it without charge pursuant to a publicly sponsored program. Ed-
ucation and counseling designed to teach safer forms of behavior
cannot be successful unless the drug-dependent person has access
to sterile injection equipment. This Article will discuss strategies
24 The decline in casual drug use is a notable achievement of efforts to reduce illicit
drug use. NATIONAL INSTITUTE ON DRUG ABUSE, NATIONAL HOUSEHOLD SURVEY ON
DRUG ABUSE: POPULATION ESTIMATES 1988 (1989). However, this reduction in casual drug
use may reflect prevention and education efforts in schools and significant cultural changes
rather than the effectiveness of current law enforcement techniques. Moreover, the decline
in casual use is more than offset by a marked increase in drug dependency and regular use
of highly addictive drugs such as cocaine. THE WHITE HOUSE, NATIONAL DRUG CONTROL
STRATEGY 1 (1989).
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aimed at making the use of sterile equipment a realistic option for
drug users.
The third public health strategy is to provide medical treat-
ment and rehabilitation so that the drug user is no longer dependent
on drugs or can satisfy the craving through lawful use of a pre-
scribed drug such as methadone. However, formidable obstacles
stand in the way of universal access to drug treatment. These
obstacles include inadequate resources for treatment facilities, the
sometimes prohibitive cost of treatment for individuals, zoning
laws, and methadone regulations. This Article will develop ideas
for substantially increasing the role of the health care and criminal
justice systems in the treatment of drug dependency.
None of these strategies, standing alone, will significantly
impede the spread of HIV in the drug-dependent population. But
the cumulative effect of education, counseling, and outreach to
reduce sharing of works; of clean-needle programs to increase the
use of sterile injection equipment; and of comprehensive medical
treatment in specialized and mainstream health facilities to reduce
dependence on drugs provides the best opportunity to impede the
needle-borne HIV epidemic. The political justification for the
sweeping changes in law, policy, and public funding needed to
meet this health imperative is found in saving the lives and health
dollars of the drug-dependent population, their sexual and needle-
sharing partners, their children, and, ultimately, the general pop-
ulation. A public health policy not only would effect a fundamental
reduction in the morbidity and mortality stemming from the HIV
epidemic, but would also lessen the severity of future needle-borne
epidemics, which, as history has already demonstrated, will occur.
I. Education About Risk Avoidance Practices: Public Policies
Designed to Reduce Sharing of Drug Paraphernalia
The sharing of works is the most critical factor in the trans-
mission of HIV in the IV drug use populations.2 Works are usually
21 See, e.g., Becker & Joseph, AIDS and Behavioral Change to Reduce Risk: A Review,
78 AM. J. PUB. HEALTH 403 (1988); Chaisson, Moss, Onishi, Osmond & Carlson, Human
Immunodeficiency Virus Infection in Heterosexual Intravenous Drug Users in San Fran-
cisco, 77 AM. J. PUB. HEALTH 169 (1987); Schoenbaum, Hartel, Selwyn, Klein, Davenny,
Rogers, Feiner & Friedman, Risk Factors for Human Immunodeficiency Virus Infection in
Intravenous Drug Users, 321 NEw ENG. J. MED. 874 (1989). For a useful description of
the social context of needle sharing, including friendship networks and shooting galleries,
see NATIONAL RESEARCH COUNCIL REPORT, supra note 7, at 190-93.
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shared out of practical necessity, but sometimes sharing of works
occurs as part of the drug subculture, as a form of social bonding
or camaraderie within the group.26 Drug-dependent persons share
works with sexual partners, members of a friendship group or
other users in a "shooting gallery." 27 A shooting gallery is a place
where a person can inject illicit drugs. Most galleries are located
near a "copping" place where drugs can be purchased. 28 Needles
are sometimes obtained "free" with the drug purchase; 29 others,
kept by dealers for renting or lending to customers, are called
"house works. '30 After the house works are used, they are then
returned and used again by another customer. Needles and sy-
ringes may be used repeatedly in this way until they become
clogged with blood, too dull to use, or break. 3' Most users in
research studies report that they obtain their needles from street
sellers and shooting galleries.32 Shooting galleries and house works
26 See Des Jarlais, Chamberland, Yancovitz, Weinberg & Friedman, Heterosexual
Partners: A Large Risk Group for AIDS, 2 LANCET 1346 (1984); Des Jarlais, Friedman,
Sotheran & Stoneburner, The Sharing of Drug Injection Equipment and the AIDS Epidemic
in New York City: The First Decade, in NIDA MONOGRAPH No. 80, supra note 14, at 160,
163-64; Dolan, Black, DeFord, Skinner & Rabinowitz, Characteristics of Drug Abusers
that Discriminate Needle-Sharers, 102 PUB. HEALTH REP. 395 (1987); Friedman, Des Jarlais
& Sotheran, AIDS Health Education for Intravenous Drug Users, 13 HEALTH EDUC. Q.
383, 385 (1986); Feldman & Biernacki, supra note 14, at 32-34.
As one commentator put it: "Although pre-AIDS sharing of injection equipment re-
flected positive social relationships among IV drug users in overcoming limited supplies of
injection equipment, IV drug users must now come to understand that sharing unsterilized
injection equipment can lead to a protracted and painful death." Des Jarlais & Friedman,
supra note 16, at 869; see Conviser & Rutledge, The Need for Innovation to Halt AIDS
Among Intravenous Drug Users and Their Sexual Partners, 3 AIDS & PuB. POL'Y. J. 43
(1988).
27 For economic reasons, shooting galleries are usually located in areas with a high
concentration of IV drug users. Des Jarlais & Friedman, Transmission of HIV Among
Intravenous Drug Users, in AIDS: ETIOLOGY, DIAGNOSIs, TREATMENT AND PREVENTION
385 (V.T. DeVita, S. Hellman & S.A. Rosenberg eds. 1988). Also, they are more frequently
located in the Northeast Corridor of the United States than on the West Coast, although
San Francisco hotels where drug users gather provide a similar setting. Feldman & Bier-
nacki, supra note 14, at 32.
2 Des Jarlais & Friedman, supra note 27, at 385-95.
29 Des Jarlais & Friedman, supra note 16, at 867; Stryker, supra note 10, at 722.
30 Des Jarlais & Friedman, supra note 27, at 386.
31 Des Jarlais, Friedman, Sotheran & Stoneburner, supra note 26, at 164; see also
Hopkins, Needle Sharing and Street Behavior in Response to AIDS in New York City, in
NIDA MONOGRAPH No. 80, supra note 14, at 18, 24 (in one study, users said they used
the same needle to inject drugs 1 (19%), 2-5 (36%), 6-21 (31%), more than 21 (11%) times).
32 The majority of shooters surveyed buys its needles from street sellers (45%) and
shooting galleries (16%). Injection equipment is also obtained from doctors or pharmacies(20%) and diabetics (8%). Some sellers steal needles from hospital garbage bins or forge
prescriptions. Hopkins, supra note 31, at 25. Some "former addicts report extensive use
of 'hitters' (a person who find[s) a vessel for injection for a fee without regard for sterile
technique)." D'Aquila & Williams, Epidemic Human Immunodeficiency Virus (HIV) Infec-
tion Among Intravenous Drug Users, 60 YALE J. BIo. MED. 545, 553 (1987).
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are particularly detrimental to the public health because they in-
volve sharing needles beyond a small group of friends or sexual
partners.
Current education programs have successfully disseminated
basic information about how AIDS is transmitted. 33 However, a
striking dissonance still exists between what IV drug users know
and how they behave.3 4 Even though many addicts know that
sharing is a high-risk behavior, they continue to share works be-
cause drug-dependent people going through withdrawal are con-
cerned primarily with a rapid injection of heroin or cocaine.35
Possession of heroin itself may create a premature withdrawal and
craving in a long-term addict through a form of classical condi-
tioning.3 6 Withdrawal is extremely unpleasant, and thus an addict
will not stop to plan or consider the health consequences when he
31 E.g., Des Jarlais & Friedman, HIV Infection Among Intravenous Drug Users: Epi-
demiology and Risk Reduction, 1 AIDS 67, 70 (1987); Feldman & Biernacki, supra note
14; Friedman, Des Jarlais & Sotheran, supra note 26, at 386 (93% of the sample knew that
IV drug use was a way to get AIDS); Selwyn, Feiner, Cox, Lipshultz & Cohen, Knowledge
About AIDS and High Risk Behavior Among Intravenous Drug Abusers in New York City,
1 AIDS 247 (1987) (97% of the sample had accurate AIDS-related knowledge); Stimson,
Donoghoe, Alldritt & Dolan, HIV Transmission Risk Behavior of Clients Attending Syringe-
Exchange Schemes in England and Scotland, 83 BRIT. J. ADDICTION 1449, 1451 (1988)
(95% of the sample had accurate AIDS-related knowledge).
3 Becker & Joseph, supra note 25. See also Ginzburg, French, Jackson, Hartsock,
MacDonald & Weiss, Health Education and Knowledge Assessment of HTLV-Ill Diseases
Among Intravenous Drug Users, 13 HEALTH EDUC. Q. 373, 377 (1986) (although the study
shows a high level of knowledge about AIDS, the survey was unable to determine what
modifications in their behavior IV drug users make based on this knowledge). Studies show
that a high proportion of addicts repeatedly use the same contaminated needle, and share
needles with intimate partners, dealers and casual acquaintances. Black, Dolan, DeFord,
Rubinstein, Penk, Rabinowitz & Skinner, Sharing of Needles Among Users of Intravenous
Drugs, 314 NEw ENG. J. MED. 446 (1986) (those reporting sharing did so in 40% of all drug
use episodes); Feldman & Biernacki, supra note 14, at 32 (sharing injection equipment was
"common"); Hopkins, supra note 31 (53% of the sample report always or sometimes sharing
injection equipment); Magura, Grossman, Lipton, Siddiqi, Shapiro, Marion & Amann,
Determinants of Needle Sharing Among Intravenous Drug Users, 79 AM. J. PUB. HEALTH
459 (1989); Stimpson, Donoghoe, Alldritt & Dolan, supra note 33 (36% of the sample report
always or sometimes sharing injection equipment); Watters, A Street-Based Outreach
Model of AIDS Prevention for Intravenous Drug Users: Preliminary Evaluation, in CON-
TEMPORARY DRUG PROBLEMS 411, 412 (1987) (over 90% of sample said that injection
equipment is typically shared). Several studies also suggest that the sexual behavior of
drug users is highly resistant to change. Des Jarlais & Friedman, supra note 16, at 866-67;
Des Jarlais & Friedman, supra note 13, at 270 (five studies all found a higher percentage
of intravenous drug users adopting risk-reduction activities relating to needle use than in
sexual behavior).
31 Stimson, Donoghoe, Alldritt, Dolan, supra note 33 (drug users in the sample reported
that they shared injection equipment because of the scarcity of equipment (51%), need for
a fix (50%) and/or peer influence (35%)); Becker & Joseph, supra note 25.
3 Des Jarlais, Friedman & Hopkins, Risk Reduction for the Acquired Immunodefi-
ciency Syndrome Among Intravenous Drug Users, 103 ANNALS INTERNAL MED. 755 (1985).
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is in need of a fix. Research indicates that addicts will use whatever
equipment is available when they are in withdrawal.3 7 Users, how-
ever, cannot rely on dealers and shooting gallery proprietors as a
safe source of sterile equipment, since these dealers and proprie-
tors sometimes repackage contaminated needles and syringes and
sell them as new.38 Since sterile injection equipment is not readily
available, education programs must teach drug users how to ster-
ilize the needles and syringes by themselves.
Risk-reduction education must also be designed to overcome
the ingrained behavior of needle sharing and to help form new
patterns of behavior in the drug-dependent population. Although
complete abstention from drug use is an admirable goal, for many
it will never be achieved. If society truly desires to promote health
and save lives among persons who continue to inject drugs, risk-
reduction education is critically important.
A. Can Education Work?
Public and political opposition to risk-reduction programs are
evident across the nation.39 Opponents often argue that these pro-
grams, are unlikely to be effective because of the inherent char-
acteristics of the IV drug-using population: physiological depen-
dence, illiteracy and lack of formal education.4 ° Opponents of risk
reduction also argue that drug users have a fundamental lack of
concern about their health. Finally, opponents point to the diffi-
culty of reaching a group engaged in a criminal enterprise that the
dominant population regards with hostility.
37 D'Aquila & Williams, supra note 32, at 553; Des Jarlais, Friedman & Hopkins, supra
note 36.
3Des Jarlais & Hopkins, Free Needles for Intravenous Drug Users at Risk for AIDS:
Current Developments in New York City, 313 NEw ENG. J. MED. 23 (1985).
39 To be sure, much of this opposition is grounded upon profound moral disapproval
of the drug-dependent population and its culture. See, e.g., Lambert, Myers Opposes
Needle Projects to Curb AIDS, N.Y. Times, Apr. 10, 1990, at B4, col. 6; LaFranchi, Texas
Program on AIDS and Addicts Hits Snag, Christian Science Monitor, Mar. 16, 1988, at 7,
col. 2.
40 Many people stereotype drug users as incapable of change. It is suggested that they
do not fear, and are not concerned with, the risks of contracting HIV because they already
accept significant health risks by taking drugs in the first place. In short, they are viewed
as having a fatalistic acceptance of the risk of death as part of their lifestyle. See, e.g.,
Beck, Changing Behavior is a Prescription Many Still Resist, Chicago Tribune, June 15,
1989, at 23, col. 1.
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Arguments that risk-reduction programs cannot be effective
ignore relevant data.41 Studies show that an overwhelming majority
of users know and understand the behavior that puts them at risk
for HIV infection.42 More significantly, drug-dependent persons
have shown a willingness to change socially ingrained activities-
evidenced by greater use of sterile injection equipment, fewer
needle-sharing partners, and less IV drug use-when provided with
education and counseling and given the means to change their
behavior.43 As a result of risk-reduction programs, drug users are
demanding that dealers and proprietors of shooting galleries pro-
vide sterile injection equipment. 44 They have also sought out public
health department programs, such as bleach and sterile needle
distribution, and drug treatment. 45 Thus, risk-reduction education
has successfully disseminated important information to drug users.
An education program aimed at teaching drug users needle steril-
ization techniques and at breaking down sharing behavior should
be similarly successful.
41 Some, probably most, intravenous drug users have altered their needle-sharing be-
havior to avoid the risk of transmission of HIV. Des Jarlais & Friedman, HIV and Intra-
venous Drug Use, 2 AIDS S65, S65-66 (Supp. 1, 1988); Des Jarlais, Friedman & Stone-
burner, supra note 12, at 156; Friedman, Des Jarlais, Sotheran, Garber, Cohen & Smith,
AIDS and Self Organization Among Intravenous Drug Users, 22 INT'L J. ADDICTIONS 201
(1987); Guydish, Abramowitz, Woods, Black & Sorenson, Changes in Needle Sharing
Behavior Among Intravenous Drug Users: San Francisco, 1986-1988, 80 AM. J. PuB.
HEALTH 995 (1990); Selwyn, Feiner, Cox, Lipshultz & Cohen, Knowledge About AIDS
and High Risk Behavior Among Intravenous Drug Abusers in New York City, 1 AIDS 247
(1987). See also Centers for Disease Control, Risk Behaviors for HIV Transmission Among
Intravenous Drug Users Not in Treatment, 39 MoRB. & MORT. WKLY REP. 273 (1990);
Friedman, Des Jarlais & Sotheran, supra note 26. Similar reductions in needle sharing are
reported in Europe, including parts of Italy, France and the United Kingdom. Olievenstein,
Drug Addiction and AIDS in France in 1987, in NIDA MONOGRAPH No. 80, supra note
14, at 114; Stimson, Injecting Equipment Exchange Schemes in England and Scotland, in
NIDA MONOGRAPH No. 80, supra note 14, at 89; Tempesta & Di Giannantonio, Sharing
Needles and the Spread of HIV in Italy's Addict Population, in NIDA MONOGRAPH No.
80, supra note 14, at 100.
42 See supra note 33.
41 E.g., Becker & Joseph, supra note 25, at 403; Des Jarlais & Friedman, supra note
41, at S70-71; Robertson, Skidmore & Roberts, HIV Infection in Intravenous Drug Users:
A Follow-Up Study Indicating Changes in Risk-Taking Behaviour, 83 BRIT. J. ADDICTION
387 (1988).
4 Des Jarlais, Friedman & Hopkins, supra note 35, at 758. Almost 82% of the needle
sellers queried reported demand for sterile injection equipment increased since the AIDS
epidemic, although only a small proportion of them attributed the increased demand directly
to the AIDS epidemic. High street prices also reflect the increased demand for sterile
equipment. A 25-cent needle and syringe could cost $2.00-5.00 on the illicit market. Des
Jarlais & Friedman, supra note 41, at S66.
45 Des Jarlais & Friedman, supra note 33, at 73; Des Jarlais & Friedman, supra note
41, at S65 ("It is now safe to conclude that some, probably most, intravenous users will
change their behavior in order to reduce their chances of developing AIDS").
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B. Current Education Policies
The Congress and many states have already mandated AIDS
education. 46 Yet the statutes that implement these mandates are
quite general, often stating only that public health departments
should provide "AIDS education." 47 Many statutes concentrate
their efforts on low-risk populations such as the general public,
school or university students, or marriage applicants. 48 Moreover,
the ongoing tension between law enforcement and public health
objectives has led to ambivalent policies and ineffective educa-
tional programs.
The Congress' ambivalence toward AIDS education is mani-
fested in the federal Health Omnibus Programs Extension Act of
1988.49 The 1988 Act thwarts public health objectives by allowing
morality-based law enforcement goals to distort its educational
message. The Act prohibits, inter alia, obscene informational ma-
terials and educational programs designed directly to promote or
encourage homosexual or heterosexual activity or intravenous sub-
stance abuse.50 Almost paradoxically, the Act goes on to say that
this limitation should not be construed to restrict the ability of an
education program to provide accurate information. The ambiva-
lent approach of the federal Health Omnibus legislation has been
adopted in at least seven states. These states require schools to
stress abstinence from sex and substance abuse.51 The dominance
of law enforcement over public health in educational programs is
also found in the federal Anti-Drug Abuse Act of 1988.52 That Act
4See Barnes, Towards Ghastly Death: The Censorship of AIDS Education, 89 COLUM.
L. REV. 698 (1989); Clark, AIDS Prevention: Legislative Options, 16 AM. J. LAW & MED.
107, 108-30 (1990); Gostin, Public Health Strategies for Confronting AIDS: Legislative
and Regulatory Policy in the United States, 261 J. A.M.A. 1621, 1624 (1989).
47 See, e.g., 1987 Conn. Acts 389, §§ 19a-121c (Reg. Sess.) (directing the state de-
partment of health services "to establish a public information program for the distribution
of materials . ..on AIDS"); ARK. STAT. ANN. § 20-15-902 (1988) (requiring the state
department of education and health to conduct public education seminars, but not specifying
the type of information to be provided, the frequency of the seminars or the source of
funding for the seminars).
48 A few states, however, specifically direct public health departments to distribute
graphic literature to higher risk groups including IV drug users. See Gostin, supra note 46.
49 For a discussion of the conflict between health education goals and current govern-
ment policy, see Gostin, A Decade of a Maturing Epidemic: An Assessment and Directions
for Future Public Policy, 16 AM. J. LAW & MED. 1 (1990).
10 See 42 U.S.C. § 300dd-32(e) (1988).
-" See Gostin, supra note 46, at 1624.
52 See 42 U.S.C. § 300x-3(c) (1988).
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prohibits most federal funding for programs providing drug users
with clean needles.
Restrictions on education impede the ability of public health
officials to disseminate effective AIDS prevention materials. It is
difficult to instruct a person to inject a drug safely without tacitly
encouraging drug use. Instructional programs also cannot be ef-
fective unless they provide the instruments for behavioral change,
in this case clean needles. Efforts to stifle candid materials that
discuss safer injection practices and provide the means to do so
may take a toll in human lives. Of course, it can be argued that
advertisements that advise drug users to "use clean needles" or
show them how to sterilize their works conform with the law
because they encourage precaution, not drug use. Still, in a con-
servative political climate federal administrators or law enforcers
might chill the presentation of effective educational materials, par-
ticularly if the materials were accompanied by a vial of bleach or
a sterile hypodermic needle.
Statutes that control the content of educational messages do
so on moral, not public health or legal grounds. However, law-
makers should not be overly concerned with morality in this area.
Instead, their overarching concern must be to secure changes in
behavior that are conducive to the health of the drug-dependent
population. Legislatures must understand that behaviors of a phys-
ically addicting or socially habitual nature are difficult to alter.
Drug users require focused, graphic information about the safer
use of drug paraphernalia, where it can be obtained, and the most
effective methods for needle sterilization. Thus, the information
must be explicit, understandable and directly relevant to the target
audience.
C. Proposals for an Effective Education Program
Risk-reduction theory and research provide useful leads for
developing effective education programs and policies. Two com-
ponents of efficacious educational programs are promoting knowl-
edge about how to behave more safely to avoid contracting HIV
and altering social organizations and cultural rituals surrounding
the sharing of drug-injection equipment. 53 The critical variables are
53 Social learning theory suggests three components for successful health education:
19911
128 Harvard Civil Rights-Civil Liberties Law Review [Vol. 26
the process of dissemination and the content of the educational
messages.
1. Education in the Sterilization of Works
Existing public health education programs have broadly ac-
complished the goal of providing basic information to drug users
about HIV transmission. Drug users demonstrate high knowledge
of the fact that sharing of equipment can transmit HIV.54
Health education programs, however, have had much less
success in providing clear, practical instruction on how to disinfect
injection equipment. Rituals for cleaning injection equipment al-
ready exist among intravenous drug users, but often are ineffec-
tive.5 5 Many IV drug users "clean" their hypodermic needle and
syringe by flushing them with tap water. Flushing with water may
unclog the equipment and make it appear visibly clean, but it does
not destroy the AIDS virus.5 6 Studies of needles and syringes
discarded at shooting galleries show the presence of the virus in
works that have no visible signs of blood. 7
Educational programs should move beyond providing basic
information about how HIV is transmitted and start including prac-
tical and simple instruction on the safest and most convenient
methods for sterilizing injection equipment. Of the various meth-
ods of effective sterilization, most public health officials advocate
knowledge, increased availability of means for behavior change, and reinforcement of new
behavioral patterns. Des Jarlais & Friedman, AIDS Prevention Among Intravenous Drug
Users: Experience in High Prevalence States, in AIDS IN CHILDREN, ADOLESCENTS AND
HETEROSEXUAL ADULTS: AN INTERDISCIPLINARY APPROACH TO PREVENTION 396 (R.F.
Schinazi & A.J. Nahmias eds. 1988); Des Jarlais & Friedman, supra note 16, at 865; see
also A. BANDURA, SOCIAL LEARNING THEORY (1977).
- See supra note 33 and accompanying text.
5- D'Aquila & Williams, supra note 32, at 553-60 (in a study in San Francisco, prac-
tically all users cleaned their equipment prior to injection, yet fewer than 20% used methods
that provide effective decontamination. Even those who effectively decontaminate their
needles may undermine their efforts by not disinfecting the cooker).
' See Watters & Cheng, HIV Infection and Risk Reduction Among Intravenous Drug
Users in San Francisco: Preliminary Results and Implications, 14 J. CONTEMP. DRUG
PROBS. 397 (1987).
57 Chitwood, McCoy, Inciardi, McBride, Comerford, Trapido, McCoy, Page, Griffin,
Fletcher & Ashman, HIV Seropositivity of Needles from Shooting Galleries in South
Florida, 80 AM. J. PUB. HEALTH 150, 152 (1990). (Needles were collected from shooting
galleries and tested for the presence of HIV antibodies. When the needles appeared to
contain blood residue, 20% were HIV-positive; where there was no visible blood residue,
5.1% were HIV-positive. These findings suggest that needles used in shooting galleries are
vectors of transmission, and that although visual inspection of the needles may be useful,
even "clean" needles may result in transmission of infection.)
Drug Dependency and AIDS
the use of household bleach because it is both readily available
and highly effective in decontaminating the equipment.5 8 Immer-
sion of a hypodermic needle and syringe in a diluted bleach solu-
tion (10:1) will effectively decontaminate the works. Other meth-
ods are less convenient or effective. Boiling the "works" can kill
the virus, but the fifteen minutes needed for this to be effective is
too long for a drug user to wait when in withdrawal. A seventy-
percent solution of isopropyl alcohol can also kill the virus, but
this is a substance that drug users might be tempted to ingest,
causing health risks of its own. Moreover, intravenous drug users
may employ the lesser strengths of alcohol found in wine, beer or
gin, in the mistaken belief that they are effective disinfectants. 59
2. Altering Social Organizations and Cultural Rituals
Some drug users report that even if they did have access to
sterile equipment, they would still share works because others in
their social group continue to do so. 60 Sharing is associated with
initiation into IV drug use and, thereafter, serves as a social bond-
ing mechanism. 61 In order to change an individual's sharing be-
havior, education, counseling and outreach must seek to change
practices in the social organizations to which users belong. As
indicated earlier, much of the necessary change in social organi-
zations may result simply from effective educational programs.
Penetrating the insular culture of IV drug users to alter the
social fabric of the group is particularly daunting. The most effec-
tive ways of altering the social organizations and cultural rituals
of drug users involve understanding their language, culture and
thinking; gaining their trust by providing services rather than pun-
ishment; and using the communication networks in their commu-
nities. Innovative programs use current and former addicts to
provide AIDS education, bleach or alcohol for sterilization, and
access to services and welfare benefits.
31 Many disinfectants will destroy the AIDS virus in vitro. But public health officials
recommend a disinfectant that is quick, inexpensive and safe. Newmeyer, Why Bleach?
Development of a Strategy to Combat HIV Contagion Among San Francisco Intravenous
Drug Users, NIDA MONOGRAPH No. 80, supra note 14, at 151, 154.
59 Stryker, supra note 10, at 722-23.
60 Des Jarlais & Friedman, supra note 16; Des Jarlais & Friedman, supra note 53.
61 See supra note 26 and accompanying text.
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Visible signs that public programs are motivated by a desire
to protect the health and lives of drug-dependent people, rather
than to stigmatize and punish them, may make it easier for an
addict to look beyond his immediate social circle for support.
Present policies that hold drug users criminally and morally ac-
countable for their behavior drive them underground and reduce
their exposure to alternate forms of behavior. Clear policies and
practices unequivocally directed toward the health of the drug-
dependent population are more likely to aid in reducing the sub-
culture's influence on users' behavior.
D. Reaching Out to the Drug-Dependent Population: Increasing
Access Points for Education and Counseling
Even if health education programs are properly designed,
there are formidable problems in making them accessible to IV
drug users. The clandestine character of the drug-dependent pop-
ulation is well known. Drug consumption activities, from the point
of purchase to the actual injection, are secret and furtive. 62 Drug-
dependent people are exceedingly hard to reach. They understand-
ably have little confidence that public officials will try to ease their
discomfort, assuage their fears and alienation, or protect their
health. Thus, drug users are unlikely to come forward voluntarily
for care.
Moreover, unlike the gay community, which is also struggling
with the HIV epidemic, IV drug users do not have organized
support, self-help, or advocacy groups. Traditional educational
approaches through television, radio and written materials are
unlikely to reach the drug subculture since, generally, this popu-
lation neither has access to nor interest in these sources of
information.
The problem of reaching drug sub-cultures can be approached
in three ways. First, support, self-help and advocacy groups for
drug-dependent people might be formed, analogous to the groups
that have been so successful in the gay community.63 Second,
addicts can be reached through the use of former addicts who
volunteer or who are paid by public health departments to interact
with drug users in shooting galleries, hotels and "copping places."
62 Feldman & Biemacki, supra note 14, at 28.
6 See R. BAYER, PRIVATE ACTS, SOCIAL CONSEQUENCES: AIDS AND THE POLITICS
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Former addicts are particularly important to successful outreach
programs because they know where drugs are bought, sold and
injected and are in the best position to gain the trust of users.
Third, educational programs must be located in places where
users are likely to go. The two systems that have the most contact
with the drug use community are the health care and criminal
justice systems. A comprehensive health care structure that could
be used to provide detailed education about practical methods for
safer drug injection already exists. Educational programs could
operate from numerous health care outlets around the country:
physicians' offices, emergency rooms, group health clinics, health
maintenance organizations, community hospitals, and clinics for
the treatment of substance abuse and sexually transmitted dis-
eases. Use of existing health care outlets for new educational
initiatives would be inexpensive. Furthermore, integrating educa-
tion into the health care system would ensure frequent exposure
to education since drug users often have multiple medical needs
that require interaction with the health care system.
Drug users also have frequent contact with the criminal justice
system. Key points of contact are arrest, trial and post-sentencing
procedures. Wide-ranging powers already exist to require testing,
education, and treatment of criminal defendants. These powers
could be exercised as a condition of bail, probation or other dis-
position. Requiring a drug user to attend testing, education and
treatment programs as an alternative to incarceration would be
more protective of the public health and safety than current non-
mandatory measures. Without systematic attempts to alter their
dependent behaviors, drug users are likely to continue their habits
both in prison and after they leave. The potential for the spread
of HIV in prison, particularly in meeting new sexual partners and
establishing new friendship groups, poses a substantial threat to
the public health. Using the connection with the criminal justice
system to provide testing, counseling, education and treatment
could be an effective way to alter a drug user's established patterns
of substance abuse and sharing of injection equipment.
II. Strategies for Increasing the Supply of Sterile Injection
Equipment
Sharing drug-injection equipment is not merely a learned re-
sponse or a function of the unfathomable culture and routines of
the drug world. Sharing is also the direct result of a limited supply
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of needles and syringes, which can deny drug users any realistic
opportunity to engage in safer behavior. This Part discusses how
the limited needle supply represents a conscious policy choice and
explores alternatives that would provide users with a readily avail-
able supply of sterile injection equipment.
Policy choices to make sterile injection equipment more avail-
able to IV drug users are fraught with political, jurisprudential and
moral conflicts. The dominant society has a fundamental ideolog-
ical objection to making injection equipment available to IV drug
users. The majority argues that such policies detract from educa-
tional messages directed to the general public, to school children
and to residents of urban areas to "say no" to drugs . 4 They argue
that legalizing possession of clean needles, and particularly dis-
tributing them, appears to condone and encourage drug use since
it provides the means for injecting illicit and dangerous substances
into the body.
Minority communities and church groups in poor inner city
areas are particularly vehement in their opposition to clean-needle
programs. Understanding the depth of feeling and the reasoning
behind such opposition is critical to future policy development in
this area. The intensity of feeling is manifested in characterizations
of the drug epidemic 65 and of the distribution of needles or even
bleach as genocidal campaigns.6 6 The social disintegration, eco-
nomic drain, morbidity and mortality associated with the drug
epidemic in poor African-American and Hispanic communities
( See Boodman, N.Y. 'Needle Exchange': Curbing AIDS or Condonin Drug Use?,
Wash. Post, Mar. 6, 1989, at Al, col. 1.
61 One prominent voice in the African American community describes the cocaine
epidemic as "Genocide, 1990's style": "when the spirit of a people is destroyed, when the
culture of a people is eradicated, when basic human relationships are ripped apart, when
large numbers of people are killed because of drug-related crimes and overdoses. I am
talking about the spiritual and physical death of a race." Williams, Crack is Genocide,
1990's Style, N.Y. Times, Feb. 15, 1990, at 31, col. 1.
6 See Kolata, Black Group Assails Giving Bleach to Addicts, N.Y. Times, June 17,
1990, at 20, col. 1 (the Black Leadership Commission on AIDS called bleach "a Trojan
horse for the African American community in that it is superficially attractive but contains
a grave element of risk"). The reaction of community leaders to New York City's needle-
exchange program is illustrative of the hostility shown. See Marriott, Needle Exchange
Angers Many Minorities, N.Y. Times, Nov. 7, 1988, at 1, col. 2 (Hilton B. Clark described
needle exchange as a genocidal campaign); Council Calls for End to Free-Needles Plan,
N.Y. Times, Dec. 7, 1988, at 10, col. I (the New York City Council voted 31-0 to dismantle
the program). The New York City needle-exchange program is described more fully in infra
notes 144-160. There are some African American and Hispanic leaders who have contin-
ually supported needle-exchange programs such as the Association for Drug Abuse Pre-
vention and Treatment (ADAPT). Marriott, supra.
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cannot be underestimated. Community leaders argue that clean-
needle programs may increase the number of injections by current
users and entice new recruits into intravenous drug use while
having only a negligible effect on the spread of HIV infection.
Even if there are no data demonstrating these harmful effects of
clean-needle programs, there is revulsion at the thought that poor,
minority communities will bear the risk of experimentation. 67
Public health officials who disregard minority objections to
clean-needle programs not only reaffirm the perceptions of indif-
ference to and disrespect for minority views, but also fail to serve
the health of the community. Cooperation through shared human
resources is necessary for successful public health programs in the
inner city. Health officials will undermine public confidence if they
thrust a program on a community that resents it, fears it and has
its reasoned arguments discounted. A clean-needle program forced
upon an untrusting community will almost certainly fail.
This Article's purpose is not to force clean-needle programs
upon minority communities. Rather, it presents data showing that
clean-needle programs, in combination with an array of health
care, prevention and educational services, would stem the epidem-
ics of drug use and HIV infection that have overwhelmed minority
communities. The policy analysis may be framed in this question:
if we were to start with no prohibitions on the sale and distribution
of drug paraphernalia-and with no political symbolism attached
to such distribution-would we adopt policies strictly limiting the
supply of sterile injection equipment? To answer this question it
is necessary first to explain paraphernalia laws; second, to examine
their objectives and whether these objectives are met; and third,
to consider what policy alternatives exist.
A. Present Statutory Limitations on the Sale, Distribution or
Possession of Syringes and Needles
As early as 1921 the United States Supreme Court recognized
the states' authority to exercise their police power to regulate the
manufacture, sale, prescription and use of dangerous drugs. 68 The
67 Rev. Reginald Williams of the Addicts Rehabilitation Center in East Harlem asked
of the New York needle-exchange program: "Why must we again be the guinea pigs in this
genocidal mentality?" Marriott, supra note 66.
6s See Minnesota ex rel. Whipple v. Martinson, 256 U.S. 41 (1921).
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court subsequently made clear that the "range of valid choice
which a State might make in this area is undoubtedly a wide one
... ."69 Pursuant to these broad powers, states have long main-
tained a policy of limiting the supply of equipment needed for the
injection of illegal drugs.
Although a state cannot constitutionally penalize a person's
drug-dependent status, 70 it clearly has constitutional authority to
control the instruments of drug use, even in the case of a person
who has no control over her habit. 71 Broadly speaking, there are
two categories of legislation that directly affect the supply of sterile
drug-injection equipment: drug-paraphernalia laws and needle-pre-
scription laws.
1. Drug-Paraphernalia Laws
Drug-paraphernalia laws are in effect in virtually every state
in the nation.72 These statutes ban the manufacture, sale, distri-
69 Robinson v. California, 370 U.S. 660, 665 (1962); see Whalen v. Roe, 429 U.S. 589
(1977).
70 See Robinson, 370 U.S. 660 (state law that made the "status" of drug dependence a
criminal offense for which a person could be prosecuted at any time before he reformed
violated the fourteenth amendment).
71 Indeed, the state probably could prohibit the public appearance of a person under
the influence of drugs, "which may create substantial health and safety hazards ... , and
which offends the moral and esthetic sensibilities of a large segment of the community."
Powell v. Texas, 392 U.S. 514, 532 (1968). In Powell the Supreme Court upheld the
conviction of an alcoholic for public drunkenness. The Court distinguished Powell from
Robinson because in Powell the state did not seek to punish the mere status of drug
dependency, nor did it attempt to regulate a person's behavior in the privacy of his own
home. Still, the Court would allow a person to be convicted, not for possessing and using
an illicit substance but merely for being under its influence in public. This comes perilously
close to allowing a status offense provided the person exhibits signs of physical dependence
in public. Courts have also upheld the constitutionality of drug-paraphernalia laws despite
the claim that they violate the eighth amendment prohibition against cruel and unusual
punishment. Convictions for possession of injection equipment have been upheld even
though the equipment was used to satisfy a craving for an addictive narcotic such as heroin.
Wheeler v. United States, 276 A.2d 722 (D.C. 1971); People v. Nicholson, 64 Cal. App. 3d
Supp. 31, 134 Cal. Rptr. 623 (1976); see Tompkins v. United States, 272 A.2d 100 (D.C.
1970) (the court saw no need to consider defendant's eighth amendment claim regarding a
drug-paraphernalia conviction because there was no evidence that he was addicted to
heroin).
72 Forty-five states and the District of Columbia have enacted drug-paraphernalia laws.
In all jurisdictions the statutes are drawn broadly enough to include the prohibition of
syringes and hypodermic needles. Thirty-six of these states and the District of Columbia
have laws based upon the MODEL DRUG PARAPHERNALIA AcT (Drug Enforcement Admin-
istration 1979). The Model Act is reprinted in Note, The Model Drug Paraphernalia Act:
Can We Outlaw Headshops-and Should We?, 16 GA. L. REV. 137 (1981). The other nine
states have enacted similar statutes.
The jurisdictions that have followed the Model Act are Alabama, ALA. CODE § 13A-
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bution or possession of a wide range of devices if it is known that
they may be used to introduce illicit substances into the body.
Drug-paraphernalia laws, therefore, require criminal intent to sup-
ply or use the equipment for an unlawful purpose.73 Selling or
12-260 (1989); Arizona, ARiz. REV. STAT. ANN. § 13-3415 (1989); Arkansas, ARK. STAT.
ANN. §§ 5-64-403, -505, -802, -805 (1990); California, CAL. HEALTH & SAFETY CODE
§§ 11014.5, 11364.5, 11364.7 (Deering 1990); Connecticut, CONN. GEN. STAT. §§ 21a-240,
-262, -267, -270, -271, -277 (1985); Delaware, DEL. CODE ANN. §§ 4701,4771-75,4784 (1983
& Supp. 1988); District of Columbia, D.C. CODE ANN. §§ 33-601 to -604 (1990); Florida,
FLA. STAT. §§ 893.145-147 (1989); Georgia, GA. CODE ANN. §§ 16-13-32.1 to -32.2 (1990);
Idaho, IDAHO CODE §§ 37-2701, -2732, -2734A, -2734B, -2740, -2744, (1990); Indiana, IND.
CODE ANN. § 35-48-4-8.1-3 (Burns 1985 & Supp. 1990); Kansas, KAN. STAT. ANN. §§ 65-
4150 to -4158 (1988); Kentucky, KY. REV. STAT. ANN. §§ 218A.500, .510 (Michie/Bobbs-
Merrill 1989); Louisiana, LA. REV. STAT. ANN. §§ 40:1031 to :1036 (1989); Maine, ME.
REV. STAT. ANN. § 1111-A (1989); Maryland, MD. CODE ANN., art. 27, § 287A (1987);
Massachusetts, MASS. GEN. LAWS ANN. ch. 94C, § 321 (West 1990); Minnesota, MINN.
STAT. §§ 152.01, .092-.095, .205 (1990); Mississippi, Miss. CODE ANN. § 41-29-139, -153
(1990); Missouri, Mo. REV. STAT. § 195.010, .135, .140, .233, .235, .244 (1989); Montana,
MONT. CODE ANN. §§ 45-10-101 to -107 (1989); Nebraska, NEB. REV. STAT. §§ 28-439 to
-440 (1989); Nevada, NEV. REV. STAT. §§ 453.554, .556, .558, .560, .562, .564, .566 (1986);
New Jersey, N.J. STAT. ANN. §§ 2C:36-1 to -9, 24:21-51 to -53 (1987); New Mexico, N.M.
STAT. ANN. §§ 30-31-2, -25.1, -34, -35 (1984 & Supp. 1990); North Carolina, N.C. GEN.
STAT. § 90-113.20 to .24 (1985); Ohio, OHIO REV. CODE ANN. § 2925.14 (Baldwin 1990);
Oklahoma, OKLA. STAT. tit. 63, §§ 2-101, -101.1, -405, -503 (1989); Pennsylvania, PA. STAT.
ANN. tit. 35, § 780-113 (1977 & Supp. 1990); Rhode Island, R.I. GEN. LAWS § 21-28.5-1 to
-4 (1989); South Dakota, S.D. CODIFIED LAWS ANN. 99 22-42A-1 to -4 (1990); Texas, TEX.
HEALTH & SAFETY CODE ANN. §§ 481.002,.111,.125,.157,.159,.183 (1989); Utah, UTAH
CODE ANN. 99 58-37a-1 to -6 (1990); Vermont, VT. STAT. ANN. tit. 18, §§ 4475-4477 (1989);
Virginia, VA. CODE ANN. 99 18.2-265.1 to .5 (1990); Washington, WASH. REV. CODE
99 69.50.102, .412 (1989); West Virginia, W. VA. CODE §§ 47-19-1 to -8, 60A-4-403a (1990);
and Wyoming, WY. STAT. §§ 35-7-1002, -1049, -1056, -1057 (1988).
The states with statutes similar to the Model Act include: Colorado, CoLo. REV. STAT.
§§ 12-22-501 to -506 (1990); Hawaii, HAW. REV. STAT. §§ 329-1, -43.5, -55 (1989); Illinois,
ILL. REV. STAT. ch. 56 1/2, 2101-07 (1988); Michigan, MICH. COMp. LAWS §§ 333.7451,
.7453, .7455, .7521 (1990); New Hampshire, N.H. REV. STAT. ANN. §§ 318-B:1, -B:2, -
B:17-b, -B:26 (1989); New York, N.Y. PENAL LAW §§ 220.50, .55 (McKinney 1990);
Oregon, OR. REV. STAT. §§ 475.525, .535, .545, .555, .565 (1989); Tennessee, TENN. CODE
ANN. §§ 39-17-402, -424, -425 (Supp. 1990); and Wisconsin, 1989 Wis. Laws 121.
See also Pascal, Intravenous Drug Abuse and AIDS Transmission: Federal and State
Laws Regulating Needle Availability, in NIDA MONOGRAPH No. 80, supra note 14, at 124
(setting forth a slightly different list of state statutes based on the Model Act).
73 The Model Drug Paraphernalia Act makes the following behaviors into criminal
offenses under the UNIFORM CONTROLLED SUBSTANCES ACT, 9 U.L.A. Part 11 (1988): to
use or intend to use paraphernalia for the introduction of drugs into the human body; to
deliver or possess with intent to deliver drug paraphernalia, knowing or reasonably knowing
that it will be used to introduce drugs into the human body; to deliver paraphernalia to a
minor with intent; and to advertise paraphernalia where a person knows, or should know,
that the purpose is to promote the sale of objects designed for introduction of drugs into
the human body. MODEL DRUG PARAPHERNALIA ACT, art. 2 (Drug Enforcement Admin-
istration 1979). The Model Act, then, has a wide scope, but requires knowledge or intent
to use the equipment for ingestion or injection of illicit drugs.
Most modern drug-paraphernalia laws, like the Model Act, define the prohibited activ-
ity in terms of objects "intended" for unlawful uses, "marketed" for unlawful uses or in
some other way introduce the element of intent. The requirement of intent does not refer
to that of the ultimate user of the paraphernalia but to the intent of the accused. Village of
136 Harvard Civil Rights-Civil Liberties Law Review [Vol. 26
distributing hypodermic needles and syringes where there is no
knowledge that they will be used to inject illicit drugs are not
offenses under these statutes. Thus, a pharmacist who sells hy-
podermic syringes and needles over the counter, believing they
will be used by a diabetic to inject insulin, commits no offense
under drug-paraphernalia laws.
The development of drug-paraphernalia laws can be traced
back to the 1950s. 74 The early statutes specifically prohibited the
distribution or possession of equipment used for administering
illicit drugs, including hypodermic syringes, needles and bottle cap
cookers. Some of the more broadly worded statutes rendered it
unlawful merely to possess the "instruments of a crime. ' 75 Such
statutes are no longer in force in most states because of their
vagueness and overbreadth. The laws failed because they appeared
to proscribe items that clearly had legitimate as well as illegitimate
purposes and did not require subjective knowledge or intent to use
the items for the injection of illicit substances.76
Hoffman Estates v. The Flipside, Hoffman Estates, Inc., 455 U.S. 489, reh'g denied, 456
U.S. 950 (1982). Where statutes require that an actor know or reasonably should know that
an item will be employed to use drugs, courts have found them to be constitutional. See,
e.g., Stoianoff v. Montana, 695 F.2d 1214 (9th Cir. 1983); Casbah, Inc. v. Thone, Governor
of Nebraska, 651 F.2d 551 (8th Cir. 1981), cert. denied, 455 U.S. 1005, reh'g denied, 456
U.S. 950 (1982). Moreover, courts have specifically read a scienter requirement into the
MAIL ORDER DRUG PARAPHERNALIA CONTROL AcT, 21 U.S.C. § 857 (1986), the MODEL
DRUG PARAPHERNALIA AcT (Drug Enforcement Administration 1979) and similar laws. See
Garner v. White, 726 F.2d 1274, 1279 (8th Cir. 1984); Nova Records v. Sendak, 706 F.2d
782, 787 (7th Cir. 1983); General Stores v. Bingaman, 695 F.2d 502, 504 (10th Cir. 1982);
Levas v. Antioch, 684 F.2d 446, 450 (7th Cir. 1982); Tobacco Accessories and Novelty
Craftsmen Merchants Ass'n of La. v. Treen, 681 F.2d 378, 383-85 (5th Cir. 1982); United
States v. Main Street Distributing, Inc., 700 F. Supp. 655 (E.D.N.Y. 1988).
74 Drug-paraphernalia statutes arose from a concern that criminal proscriptions of the
possession and sale of narcotics were insufficient in the fight against drugs. It was believed
that the unrestricted sale of the instruments of narcotic use actually encouraged and
glamorized its use. See Mid-Atlantic Accessories Trade Ass'n v. Maryland, 500 F. Supp.
834, 841 (D. Md. 1980). Accordingly, many states and municipalities enacted laws to prohibit
or control the sale of equipment that could be used to ingest, inhale or inject illicit
substances. See Levas v. Antioch, 684 F.2d 446 (7th Cir. 1982). Outlets used to sell drug
paraphernalia in the 1970s were often referred to as "head shops," and early attempts to
proscribe them became known as "head shop laws." See Annotation, Validity, Under
Federal Constitution, of So-Called "Head Shop" Ordinances or Statutes, Prohibiting Man-
ufacture and Sale of Drug Use Related Paraphernalia, 69 A.L.R. FED. 15 (1984); Anno-
tation, Prosecutions Based Upon Alleged Illegal Possession of Instruments to be Used in
Violation of Narcotics Laws, 92 A.L.R.3D 47 (1979).
7' See McKoy v. United States (Case 2), 263 A.2d 649 (D.C. 1970); McKoy v. United
States (Case 1), 263 A.2d 645 (D.C. 1970); Keith v. United States, 232 A.2d 92 (D.C. 1967).
76 Although the courts often reached inconsistent results, some courts had constitu-
tional difficulties with broadly worded statutes that did not contain an intent requirement.
See, e.g., Bambu Sales v. Gibson, 474 F. Supp. 1297 (D.N.J. 1979); Record Museum v.
Lawrence Township, 481 F. Supp. 768 (D.N.J. 1979). For reviews of early drug-parapher-
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The modern drug-paraphernalia laws that have replaced these
older versions establish a requirement of subjective intent. 77 How-
ever, the modern statutes still regulate a broad range of behavior:
they comprehensively proscribe the manufacture, delivery, pos-
session or advertisement of drug paraphernalia. 78 In addition, the
term "drug paraphernalia" is widely defined to include any equip-
ment, product or material of any kind that is primarily intended
for use in introducing controlled substances into the human body.79
The modern trend toward comprehensive drug-paraphernalia
laws began with the formulation of a Model Act by the Drug
Enforcement Administration of the Department of Justice in
1979.80 At least forty-seven states and the District of Columbia
have enacted the Model Act or similar legislation. 81 The United
States Supreme Court's decision in Village of Hoffman Estates v.
Flipside, Hoffman Estates, Inc. also advanced this trend. 82 The
Court upheld the constitutionality of broadly worded local laws
not based on the Model Act. Many courts have followed Flipside
and have upheld statutes with broad definitions of drug
paraphernalia.83
nalia laws, see Davis, Drug Paraphernalia Laws: Clearing A Legal Haze, 13 CUMB. L.
REV. 273 (1982-1983); Johnson, The Constitutionality of Drug Paraphernalia Laws, 81
COLUM. L. REV. 581 (1981); Katkin, Hunt & Bellington, Drug Paraphernalia in Perspective:
The Constitution and The Spirit of Temperance, 21 CriM. L. BULL. 293 (1985); Lucansky
& Hansen, Up in Smoke: A Review of Drug Paraphernalia Legislation, 70 ILL. B.J. 320
(1982).
77 See generally Pascal, supra note 72, at 119.
78 See supra note 73 and accompanying text.
79 The Model Drug Paraphernalia Act has an exceptionally broad definition that in-
cludes all equipment, products and materials of any kind that are to be used, intended for
use or designed for use, in planting, propagating, cultivating, growing, harvesting, manu-
facturing, compounding, producing, processing, preparing, testing, packaging, storing, con-
cealing, injecting, inhaling or otherwise introducing into the human body a controlled
substance in violation of the CONTROLLED SUBSTANCES AcT, 9 U.L.A. Part 11 (1970). The
definition specifically includes hypodermic syringes, needles and other objects used, in-
tended for use or designed for use in parenterally injecting controlled substances into the
human body. MODEL DRUG PARAPHERNALIA AcT, art. 1 (Drug Enforcement Administration
1979).
80 MODEL DRUG PARAPHERNALIA AcT (Drug Enforcement Administration 1979).
81 See supra notes 72-73.
8 455 U.S. 489, reh'g denied, 456 U.S. 950 (1982). Flipside concerned a facial challenge
to the overbreadth and vagueness of a municipal statute that made it unlawful for any
person "to sell any items, effect, paraphernalia, accessory or thing which is designed or
marketed for use with illegal cannabis or drugs. ... Id. at 492. The Supreme Court
upheld the constitutionality of the ordinance. The Court found that the ordinance's language
"designed ... for use" is not vague since it is clear that it encompasses items principally
used with illegal drugs because of their objective features (a "roach clip," for example). Id.
at 501. The "marketed for use" standard requires scienter on the part of the retailer.
81 See, e.g., Garner v. White, 726 F.2d 1274 (8th Cir. 1984); Camille Corp. v. Phares,
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In 1986 the federal government expanded paraphernalia pro-
hibitions by enacting an umbrella statute designed to reach any
activity involving paraphernalia crossing interstate lines.84 Al-
though the Mail Order Drug Paraphernalia Control Act of 198685
was originally designed to prohibit use of the postal service to
send drug-injection equipment, 86 the plain language of the statute
extends to "any offer for sale and transportation in interstate or
foreign commerce," of drug paraphernalia. 87 The Act also contains
a broad definition of drug paraphernalia,8 8 and it has survived
constitutional scrutiny. 89
The importance of the federal statute is its extension of federal
jurisdiction to an area traditionally reserved to the states. 90 Both
federal and state statutes allow a wide margin of discretion in
enforcement and prosecution. A state could make a deliberate
choice to repeal or not to enforce a drug-paraphernalia law based
upon the public health imperatives of the HIV epidemic. However,
even if a state were to make one of these choices, federal author-
ities conceivably could take a different view and rigorously enforce
the Mail Order Act. The Act thus creates a need to harmonize
objectives, not only between law enforcement and public health
authorities but also between federal and state agencies.
705 F.2d 223 (7th Cir. 1983); Stoianoff v. Montana, 695 F.2d 1214 (9th Cir. 1983); Levas v.
Village of Antioch, 684 F.2d 446 (7th Cir. 1982); People v. Nelson, 171 Cal. App. 3d Supp.
1, 218 Cal. Rptr. 279 (1985).
84 The exercise of police powers to protect the public health is traditionally within the
domain of the states and not the federal government. See Jacobson v. Massachusetts, 197
U.S. 11 (1905); Gostin, The Future of Public Health Law, 12 AM. J.L. & MED. 461 (1987).
However, Congress enacted the Mail Order Drug Paraphernalia Control Act in 1986 under
its constitutional authority to regulate interstate commerce. Depending on how liberally
the Act is construed and how actively it is enforced, the Act has the "potential for
dramatically inserting the Federal Government into the regulation and control of drug
paraphernalia, including hypodermic needles and syringes." Pascal, supra note 72, at 122.
85 Anti-Drug Abuse Act of 1986, §§ 1821-23, Pub. L. No. 99-570 (codified at 21 U.S.C.
§ 857 (1988)).
6 See 132 CONG. REc. H6655-56 (daily ed. Sept. 11, 1986) (statement of Rep. Levine).
'7 21 U.S.C. § 857(a) (1988).
-8 21 U.S.C. § 857(d) (1988). The Act also authorizes seizure and forfeiture of drug
paraphernalia. 21 U.S.C. § 857(c) (1988).
89 United States v. Main Street Distributing, Inc., 700 F. Supp. 655 (E.D.N.Y. 1988).
The court upheld the statute because it implied a scienter requirement. In particular, the
legislative history suggests that the intent of the accused is essential. See Mail Order Drug
Paraphernalia Control Act: Hearings on H.R. 1625 Before the Subcomm. on Crime of the
House Comm. on the Judiciary, 99th Cong., 2d Sess. 19-21 (1986). The court, following
Village of Hoffman Estates v. Flipside, Hoffman Estates, Inc., 455 U.S. 489, reh'g denied,
456 U.S. 950 (1982), also found that the statute was not unconstitutionally vague.
90 Pascal, supra note 72, at 122.
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Drug-paraphernalia laws, including the federal Mail Order Act
and comprehensive enactments at the state level, erect formidable
obstacles for IV drug users attempting to comply with public health
advice to use sterile injection equipment. Even if the user can buy
a sterile hypodermic syringe over the counter, he still can be
prosecuted under these statutes if the syringe is found in his pos-
session. In order to escape prosecution the user must demonstrate
that she has a valid medical purpose for possessing the equip-
ment.91 Drug-paraphernalia laws, therefore, not only significantly
limit the supply of sterile equipment on the street, but also provide
a marked disincentive for users to have sterile equipment in their
possession when they frequent a "copping place." Since this is
precisely the time users most need to have a sterile hypodermic
in their possession, drug-paraphernalia laws constitute a significant
barrier to effective public health practices.
2. Needle-Prescription Laws
Drug-paraphernalia laws do not prohibit or regulate the sale
of hypodermics if the seller has no reason to believe that the
equipment will be used for injection of illicit drugs. Accordingly,
over-the-counter sales of hypodermic syringes and needles are
permitted in most jurisdictions. Pharmacists are not obliged to
question the buyer's intention in purchasing the equipment, and
wide variations in sales practices exist. Some pharmacists will sell
to any buyer, while others will not sell to a buyer who shows
visible signs of intravenous drug use or who is unable to present
a plausible medical justification for his request to purchase the
equipment.92
91 A diabetic, for example, could demonstrate that she needed the syringe for the
injection of insulin.
92The scant literature on this issue suggests that there is wide variability in the practices
and attitudes of pharmacists in relation to AIDS and drug abuse. In jurisdictions where
over-the-counter sales of hypodermic syringes and needles are permitted, only a proportion
of pharmacists do in fact sell to customers they believe to be drug-dependent. Goldberg,
AIDS and Intravenous Drug Use, 294 BRIT. MED. J. 906 (1987) ("Only 16% of the phar-
macies [studied in Glasgow, Scotland] were prepared to sell needles and syringes in areas
considered to have large populations of intravenous drug users, and indeed many of these
areas had no retail source of needles and syringes whatsoever. Of those prepared to sell,
most did so reluctantly, and usually only diabetic syringes (often unacceptable to drug
users because of the size of the barrel and needle) were available"); Glanz, Byrne &
Jackson, Role of Community Pharmacies in Prevention of AIDS Among Injecting Drug
Misusers: Findings of a Survey in England and Wales, 299 BIUT. MED. J. 1076 (1989)
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Eleven states and the District of Columbia significantly restrict
over-the-counter sales of hypodermic needles and syringes. 93
These jurisdictions' "needle-prescription" laws, dating back to the
New York Boylan-Town Act of 1914, 94 prohibit the sale, distri-
bution or possession of hypodermic syringes or needles without a
valid medical prescription. 95 Needle-prescription laws are more
onerous than drug-paraphernalia laws because they do not require
criminal intent.96
Under needle-prescription laws, physicians may write pre-
scriptions for hypodermic syringes and needles for patients under
their care only if there is a legitimate medical purpose for them to
do so. A wholesale druggist or surgical supplier must keep careful
records of the sale of syringes and needles. Persons charged with
illegal possession of a hypodermic syringe or needle have the
burden of proving that they have sufficient authority or license to
possess them.97
The "legitimate medical purposes" doctrine strengthens the
regulatory effect of needle-prescription laws. The doctrine is in-
tended to hold a prescription invalid unless it is issued in good
faith for a therapeutic purpose. 98 Many physicians have had their
(measures willingness of pharmacists to sell injecting equipment to known or suspected
drug users, and their attitudes toward exchanging syringes, keeping a "sharps" box (im-
pervious container in which used needles can be discarded) for use by drug abusers and
offering face-to-face advice and leaflets; proposes promoting the participation of pharma-
cists in preventing needle sharing as a viable policy, while recognizing that attitudinal
problems would have to be overcome).
93 NATIONAL ASSOCIATION OF BOARDS OF PHARMACY, 1988-1989 SURVEY OF PHAR-
MACY LAW INCLUDING ALL 50 STATES, D.C. AND PUERTO Rico 42 (1989) (significant
restrictions on over-the-counter sales in California, Connecticut, Delaware, Illinois, Maine,
Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania and Rhode Island).
94 1914 N.Y. Laws ch. 363; see COMMITTEE ON MEDICINE & LAW, Ass'N OF THE BAR
OF THE CITY OF NEW YORK, Legalization of Non-Prescription Sale of Hypodermic Nee-
dles: A Response to the AIDS Crisis, 41 REC. A. B. CITY N. Y. 809, 811 (1986) [hereinafter
N.Y.C. B. A., Legalization]. The purpose of the Boylan-Town Act was to make it more
difficult to obtain the instruments needed for the administration of drugs. See People V.
Gordon, 336 N.Y.S.2d 753 (1972); D. MusTo, THE AMERICAN DISEASE: ORIGINS OF NAR-
COTIC CONTROL (1973).
95 See, e.g., LA. REV. STAT. ANN. § 40 (West 1977); MASS. GEN. LAWS ANN. ch.
94C, § 27 (West 1990); N.Y. PENAL LAW § 220.45 (Consol. 1989).
96 Needle-prescription laws, which are regulatory and do not impose criminal liability
on the buyer, have been upheld by courts, despite the lack of an intent requirement. See
People v. Bellfield, 33 Misc. 2d 712, 230 N.Y.S.2d 79 (1961), aff'd, 11 N.Y.2d 947, 183
N.E.2d 230 (1962). But see State v. Birdsell, 235 La. 396, 104 So. 2d 148 (1958).
97 See, e.g., Commonwealth v. Jefferson, 377 Mass. 716, 387 N.E.2d 579 (1979); MASS.
GEN. LAWS ANN. ch. 94C, § 27 (West 1990).
9Authority to possess hypodermics can also be granted under most of these laws by
the Commissioner for Health. See, e.g., N.Y. PUB. HEALTH LAW § 3381(2) (McKinney
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licenses revoked or have been convicted for improperly prescrib-
ing drugs or drug paraphernalia. 99 A physician may write a pre-
scription for a patient under her immediate charge for the admin-
istration of certain controlled substances. If the prescription is not
to treat or to cure a patient but to satisfy the craving of an addict,
the physician has overstepped the boundaries of the statute."00
Thus, a physician may not prescribe narcotics or paraphernalia to
an addict solely because he is an addict.10'
However, the constitutional boundaries of lawful prescription
are not clearly delineated. In some early cases the Supreme Court
held that prescribing an illicit drug for the purpose of relieving
conditions incident to addiction is not unlawful in every situa-
tion.10 2 Nevertheless, physicians who departed from the usual
course of medical practice were subject to the same penalties as
street pushers. 10 3
There is no customary medical practice for prescribing drug-
injection equipment. Faced with the exigencies of the HIV epi-
demic, a physician might want to prescribe a hypodermic in order
to prevent her patient from contracting or transmitting HIV. While
providing paraphernalia in this situation would not comport with
prevailing medical practice, the overwhelming consensus among
public health officials is that IV drug users should have access to
sterile equipment in order to further legitimate public health
goals.' 4
1985). The legitimate medical purposes doctrine can be traced to the Harrison Narcotic
Act of 1914, 38 Stat. 785 (1914) (codified as amended at 26 U.S.C. §§ 4701-06, repealed by
Pub. L. No. 91-513, § 1101(b)(3)(A)). The Harrison Act was ostensibly enacted as "a taxing
act with the incidental purpose of minimizing the spread of addiction to the use of poisonous
and demoralizing drugs." United States v. Balint, 258 U.S. 250, 253 (1922). The Act confines
sales of narcotics to registered physicians dispensing them for legitimate medical purposes.
United States v. Doremus, 249 U.S. 86 (1919).
99 See, e.g., Minnesota ex rel. Whipple v. Martinson, 256 U.S. 41 (1921); Jin Fuey
Moy v. United States (Case 2), 254 U.S. 189 (1920); Doremus, 249 U.S. 86; Webb v. United
States, 249 U.S. 96 (1919); United States v. Jin Fuey Moy (Case 1), 241 U.S. 394 (1915).
100 Webb v. United States, 249 U.S. 96, 99 (1919).
101 See generally Ginzburg, Illicit Drug Use in the United States: The Evolution of the
Federal Judicial and Legislative Interventions (Dec. 1988) (unpublished manuscript avail-
able from American Society of Law & Medicine, Boston, Mass.).
102 See, e.g., Boyd v. United States, 271 U.S. 104 (1926) (the mere fact that a physician
prescribes a dose of a narcotic that exceeds that required for a single dosage does not make
it unlawful); Linder v. United States, 268 U.S. 5, 18 (1925) (addicts are "diseased and
proper subjects for ... treatment"; the determination of what constitutes treatment of an
addict is primarily a concern of the physician).
103 Jin Fuey Moy, 254 U.S. at 193-94; Webb, 249 U.S. at 99-100.
14 See, e.g., Friedman, Des Jarlais & Sterk, AIDS and the Social Relations of Intra-
venous Drug Users, 68 MILBANK Q. 85 (Supp. 1 1990).
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B. The Public Health Impact of Limiting the Supply of Sterile
Injection Equipment
Denying IV drug users sterile injection equipment has been
seriously detrimental to the public health. Nevertheless, needle-
borne transmission of infectious disease was barely discussed dur-
ing formulation of the Model Drug Paraphernalia Act in 1979105 or
during decades of judicial review of drug-paraphernalia legisla-
tion. 106 Perhaps most remarkably, the federal Mail Order Drug
Paraphernalia Control Act of 1986 was enacted at the pinnacle of
our current HIV epidemic.10 7
Numerous indicators suggest that these laws have contributed
significantly to needle sharing. 08 The demand for sterile injection
equipment vastly outstrips its supply. The great majority of per-
sons selling injection equipment reports that the illicit market is
thriving. 0 9 The over-the-counter cost of a hypodermic syringe and
needle can be as low as 25 to 50 cents. Yet, the cost on the black
market is about $3.00 and sometimes as high as $10.00 for "blue" 110
syringes." While this price appears low relative to the cost of
drugs, the extremely high number of injections, particularly among
cocaine users, means that numerous hypodermics are required
over time. Although some users will pay the additional cost of
new injection equipment, they still must rely on the integrity of
dealers. Unscrupulous dealers "repackage" the equipment after
105 For the legislative history and purpose of Pub. L. No. 99-570, see 1086 U.S. CODE
CONG. & ADMIN. NEWS 5393.
106 See supra notes 72-83.
107 Anti-Drug Abuse Act of 1986, §§ 1821-23, Pub. L. No. 99-570 (codified at 21 U.S.C.
§ 857).
10s Since distribution of sterile injection equipment is unlawful, systematic research
documenting the public health impact of drug-paraphernalia and needle-prescription laws
does not exist.
109 Morgan, Inside a Shooting Gallery: New Front in the AIDS War, N.Y. Times, Feb.
6, 1988, at BI, col. 2; see also Des Jarlais, AIDS and Intravenous Drug Use, NAT'L INST.
JUST. AIDS BULLETIN, Feb. 1988, at 1, 4; Des Jarlais & Friedman, Transmission of Human
Immunodeficiency Virus among Intravenous Drug Users, in AIDS: ETIOLOGY, DIAGNOSIS,
TREATMENT, AND PREVENTION (V. DeVita, S. Hellman, and S. Rosenberg eds. 1988) at
385, 386; Hopkins, supra note 31, at 18, 26. The increased market for sterile injection
equipment is also apparent in marketing efforts to sell drugs, whereby clean needles are
provided free with the purchase of bags of heroin, or "two for one" needle sales are offered.
Council on Scientific Affairs, American Medical Association, Reducing Transmission of
Human Immunodeficiency Virus (HIV) Among and Through Intravenous Drug Abusers, 4
AIDS & PUB. POL'Y J. 3, 143 (1987) [hereinafter AMA, Reducing Transmission of HIV].
110 "Blue" is the street name for the highest-quality injection equipment.
M Des Jarlais, Friedman & Hopkins, supra note 36, at 758; Morgan, supra note 109;
see also Des Jarlais & Friedman, supra note 16, at 866; Hopkins, supra note 31, at 26.
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rinsing it out with water. And some users will save the cost of new
equipment by borrowing house works or sharing with friends.
Restricting the supply of sterile injection equipment thus increases
the incidence of unsafe sharing practices and unnecessarily aggra-
vates the HIV epidemic.
C. Proposals for Statutory Reform Consistent with Public
Health Objectives
Drug-paraphernalia laws have two ostensible objectives, nei-
ther of which they achieve. The first is to discourage illegal drug
use. However, no data support the proposition that access to
sterile injection equipment causes people to begin, continue, or
increase IV drug use.1 12 The percentage of IV drug users in the
United States has been relatively stable for many years, both
before and after the introduction of drug-paraphernalia statutes.11 3
Further, there are no reports among the research literature that
suggest that people use, or fail to use, drugs based upon the
availability of equipment. Economic incentives ensure that drug
dealers will provide some form or quality of injection equipment
to drug users. A diminished supply only means that users must
rent or share, instead of possessing their own sterile equipment.
The second objective of drug-paraphernalia laws is to give
law enforcement officers an additional ground upon which to arrest
drug users. If the police cannot charge a person for possession of
illicit drugs, they can still sustain a charge of possession of drug
paraphernalia. However, this is probably the most pernicious as-
pect of paraphernalia laws. To avoid potential prosecution, IV
drug users have learned not to carry with them any of their equip-
ment.11 4 Therefore, they are forced to use the often contaminated
equipment that they can rent or share at a shooting gallery or
112 See infra notes 121-128 and accompanying text.
113 The number of heroin users in emergency rooms in metropolitan areas across the
country, for example, increased from 1984 to 1988. Adams, Blanken, Ferguson & Kopstein,
Overview of Selected Drug Trends, in Efficacy of Drug Abuse Treatment Program, Part
1k. Hearing Before the House Select Comm. on Narcotics Abuse and Control, 101st Cong.
156 (Aug. 2, 1989). The NATIONAL INSTITUTE ON DRUG ABUSE (NIDA) NINTH PERIODIC
HOUSEHOLD SURVEY (1989) also documented an increase in serious drug use. See THE
WHITE HOUSE, NATIONAL DRUG CONTROL STRATEGY (1990).
114 AMA, Reducing Transmission of HIV, supra note 109 at 143; Connors & Galea,
Anthropological Investigations of the Meaning and Practices of Needle Use and Sharing
Among Intravenous Drug Users (IVDU), presented at the Fourth Int'l Conf. on AIDS,
Stockholm (June 1988).
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hotel. Drug users have even been arrested for carrying vials of
bleach. 115 This is based upon the questionable legal theory that
household bleach used to sterilize injection equipment can be clas-
sified as drug paraphernalia under the broad definition of para-
phernalia in modern statutes. Ironically, under this theory, drug
users attempting to engage in safer behavior would be the ones
most likely to be punished. 16
1. Narrow the Focus of Drug-Paraphernalia Laws
Drug-paraphernalia laws, if they are to be consistent with
public health objectives, should focus their prohibitions only on
the sale, rental, or distribution of drug-injection equipment, ex-
cluding possession. These prohibitions would affect a drug dealer
or proprietor of a shooting gallery, but not a health care profes-
sional, pharmacist, or druggist. The law would regulate the sale of
hypodermic syringes and needles in much the same way as existing
law-ensuring that they are sold only in appropriate places (e.g.,
pharmacies and not candy stores) by trained and experienced
professionals, and in a safe, sterile condition. However, there
would be no pretense that the authorized seller did not know what
the equipment was going to be used for. More important, the drug-
dependent person would not be chilled from buying, possessing,
or using the sterile injection equipment by the threat of criminal
sanctions. Any sale or distribution of equipment by an unauthor-
ized person, however, would continue to be subject to criminal
penalties.
These legal modifications are justified on two grounds. First,
the new law would focus its proscriptions precisely where the
u5 See Stryker, supra note 10, at 729 ("a vial of bleach would certainly tip off a
policeman who came across it while frisking a suspect, even in the absence of any drugs
or injection equipment").
116 Solutions to this problem include exercising prosecutorial discretion or simply not
enforcing drug-paraphernalia laws. Prosecutorial discretion was proposed by Pascal, supra
note 72, at 125-27. However, Stryker, supra note 10, points out that drug-paraphernalia
laws exist at federal, state, and local levels. "A consistent message must emanate from the
entire hierarchy of law enforcement officials, from the prosecutor to the cop on the beat;
the public health and criminal justice systems must operate in harmony." Id. at 729. In the
United Kingdom, chief constables and local police have announced a policy of nonenforce-
ment of drug laws. See Lohr, There's No Preaching, Just the Clean Needles, N.Y. Times,
Feb. 29, 1988, at 4, col. 1; Robertson, Bucknell, Welsby, Roberts, Inglis, Peutherer &
Brettle, supra note 12; Lezak & Leonard, The Prosecutor's Discretion: Out of the Closet,
Not Out of Control, 63 OR. L. REV. 247 (1984).
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danger to health and well-being occurs-illicit drug dealers and
shooting gallery or hotel proprietors. Illicit sellers of hypodermics
are unreliable and not subject to effective quality control or reg-
ulation. The probability that they will provide used or shared
equipment justifies the criminal proscription. Second, just as so-
ciety does not allow dealers to profit from the sale of drugs, so
too should it refuse to allow them to profit from trade in drug
paraphernalia. Drug-paraphernalia laws applied to illicit sellers
would provide an appropriate alternative vehicle for arrest or
charge. If the police can demonstrate an intent to sell drug para-
phernalia outside of a regulated pharmacy or other authorized
place, that should provide sufficient justification for prosecution,
even if the dealer is not in possession of heroin or cocaine.
A new law that focuses on illicit sale of hypodermics, but not
on authorized sale and purchase, would have the benefit of allow-
ing drug users to possess sterile equipment, thus encouraging safer
injection practices. It would also quickly end the thriving black
market for the sale of hypodermic syringes and needles, which
poses a significant danger to the health of the public. 117
2. Repeal Needle-Prescription Laws
Along with modification of drug-paraphernalia laws, some
states would also need to repeal needle-prescription laws to allow
pharmacists and other authorized retailers to sell hypodermics
over the counter, without a medical prescription. This repeal would
be less controversial than needle distribution programs" 8 because
the state would not be directly involved in the distribution of drug-
injection equipment. Moreover, repeal of these laws would have
no revenue impact for state legislatures. It would simply remove
the state as an affirmative obstacle to providing IV drug users with
the sterile equipment necessary to protect their health.
Repeal of needle-prescription legislation is already supported
by respected public health and bar associations." 9 More important,
117 The marketplace would help end the black-market sale of needles and syringes
because sterile injection equipment would be readily available to the drug-dependent person
at an inexpensive price.
118 See infra text accompanying notes 131-142.
119 See N.Y.C. B. A., Legalization, supra note 94, at 809; ABA, AIDS: THE LEGAL
IssuEs: DiscussION DRAFT OF THE ABA AIDS COORDINATING COMMITTEE 233 (1988);
Committee on Law and Reform of the New York County Lawyers Association, Report on
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thirty-nine states and several European nations already permit
over-the-counter sales of hypodermic syringes and needles.2 0 Ex-
perience in these jurisdictions shows that they are better able to
control the needle-borne spread of HIV, and that allowing over-
the-counter sales does not result in greater drug use. 121
Proposals to repeal needle-prescription laws would affect only
twelve jurisdictions. However, these are predominately areas of
high drug use and seroprevalence that have had great difficulty
controlling the needle-borne spread of HIV. These jurisdictions
include the tri-state area of New York, New Jersey, and Connect-
icut, which has some three-quarters of all nationally reported cases
of AIDS in IV drug users; other high prevalence states such as
California; and medium prevalence states such as Illinois, Mas-
sachusetts, and Pennsylvania. 122
Comparing states with needle-prescription laws and others
selected for their comparable urban populations yields two con-
clusions.123 First, the estimated percentage of HIV-infected IV
drug users is markedly higher in states that ban over-the-counter
needle sales. 24 Data from other countries that allow nonprescrip-
tion sales also show relatively lower serological prevalence in the
IV drug community. 25 Second, the overall rate of IV drug use in
states that allow over-the-counter sales is also considerably
lower. 126
Broad correlative data can only supplement the reports of
drug users and researchers that sharing occurs, in part, because
of the inaccessibility of sterile equipment. 27 Although the repeal
of needle-prescription laws alone may not significantly alter sero-
prevalence or drug use, the potential for some change in behavior
Drug Related AIDS and the Legal Ban on Over-the-Counter Hypodermic Needle Sales I
(Jan. 12, 1988) (unpublished manuscript on file with the American Society of Law and
Medicine, Boston, Mass.) [hereinafter Committee on Law and Reform Report].
120 See supra note 93 and accompanying text; infra note 167.
121 See infra note 174 and accompanying text.
122 See Committee on Law and Reform Report, supra note 119.
12 It should be noted that comparisons of jurisdictions with and without needle-pre-
scription laws have no strict scientific validity because there may be many reasons for
differential rates of infection and drug use.
124 See Committee on Law and Reform Report, supra note 119.
2 The U.S. and European data is collected by the Committee on Law and Reform of
the New York County Lawyers Association, in Committee on Law and Reform Report,
supra note 119, at 3-4.
126 See Committee on Law and Reform Report, supra note 119.
'12 See supra notes 109-111 and accompanying text.
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is high. The likelihood that repeal would have an adverse effect
on the frequency of drug use is remote. Repeal of needle-prescrip-
tion statutes need not mean that the state must abandon any at-
tempt to regulate the sale of hypodermic needles and syringes.
State legislators concerned with the sensitivity of local communi-
ties can require that sales take place only in certain locations, such
as pharmacies, and that the equipment is not placed on display in
view of customers. At the least, policy makers owe drug-depen-
dent people the opportunity and means for protecting themselves
and others from the needle-borne spread of HIV.t 28
D. Affirmative Measures: State-Sponsored Efforts to Increase
the Supply of Sterile Injection Equipment
The most frequently mentioned advantage of repealing needle-
prescription statutes is also the proposal's most notable deficiency.
Relying on private sales, as opposed to public distribution, is
politically easy because the state can claim that it plays no direct
role in supplying a disfavored population with the tools to abuse
drugs. However, if the state is not a player in needle distribution,
it loses a valuable opportunity to provide services to a hard to
reach population.
The best way to reach underserved populations is to offer
them benefits and services. Offering sterile syringes and needles
breaks down barriers of distrust by demonstrating the state's hu-
mane commitment to the health and well-being of drug-dependent
people. Needle distribution programs can also provide critically
important points of access for education, test-linked counseling, 29
distribution of bleach and condoms, and medical services including
'2 Another alternative would be to loosen the legal regulations on prescriptions for
sterile needles. Physicians could prescribe a sterile needle expressly for the purpose of
preventing transmission of disease through dirty equipment. Such prescriptions could be
filled at specially licensed pharmacies or distribution centers, where HIV education pro-
grams could occur. Clearly, there are practical problems with this approach. Physicians
who generally do not practice in the drug-dependency area would be faced with hard
choices, and physicians and pharmacists might feel uncomfortable with such a legal re-
sponsibility. Such discomfiture, however, could be addressed through separately licensing
these practitioners or pharmacies. Additionally, state licensure boards could mandate con-
tinuing education programs that would address the scope of the practitioners' duties and
constraints in this area.
"2 "Test-linked counseling" refers to HIV-related counseling provided before and after
the administration of an HIV antibody test.
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primary care and treatment for drug dependency or sexually trans-
mitted diseases.
Needle distribution programs can take many forms, ranging
from established government distribution centers to on-the-street
distribution by ex-addicts or even at vending machines.13 Most
versions of needle distribution are called "needle exchange" be-
cause drug-dependent persons can exchange used needles for ster-
ile ones. In this way the state keeps control over the number of
needles in circulation.
1. Experience with Needle Exchange and Bleach
Distribution in the United States
Needle-exchange programs in the United States are politically
charged and their establishment, even on an experimental basis,
has been seriously delayed. The overarching message of law en-
forcement and community leaders is that drug use is profoundly
detrimental to a person's health and to the social fabric of local
neighborhoods. Most drug opponents actively denounce such pro-
grams, fearing that clean-needle programs will lead to an increase
in drug use because of the mixed message a community with needle
exchange receives. While Boston leaders debated whether to adopt
a needle-exchange program, Cardinal Bernard F. Law, Catholic
Archbishop of Boston, said, "The answer to drugs must be an
unequivocal no. It is difficult to say that convincingly while passing
out clean needles.' 131 Law enforcement and community leaders
recognize the conflict between legal and moral dictates and public
130 A needle-exchange program in Tacoma, Washington was begun by a former drug
counselor, David Purchase, in violation of state law, but with the support of the chief of
police. Subsequently, the city voted to pay Mr. Purchase a salary and to institute the
program formally. See Gross, Needle Exchange for Addicts Wins Foothold Against AIDS
in Tacoma, N.Y. Times, Jan. 23, 1989, at A8, col. 4; see also SAN FRANCISco AIDS
FOUNDATION, NEEDLE EXCHANGE PROGRAMS 9-11 (1989). In other instances the author-
ities have not been so understanding. Jon C. Parker, a student at the Yale School of Public
Health and an ex-addict, broke state needle-prescription laws by distributing injection
equipment to addicts in Massachusetts and Connecticut. He was arrested in Boston, but
the Judge subsequently dismissed the charges without explanation. Lambert, AIDS Battler
Gives Needles Illicitly to Addicts, N.Y. Times, Nov. 20, 1989, at Al, col. 1.
131 Bostonians Split on Mayor's Idea of Needle Swap, N.Y. Times, Mar. 24, 1988, at
A16, col. 1; see also Primm, Needle Exchange Programs Do Not Solve the Problem of
HIV Transmission, AIDS PATIENT CARE, Aug. 1989, at 18, 20 ("[s]upplying addicts with
needles and syringes gives the wrong message and muddies the whole effort of stopping
people from using drugs").
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health objectives but consistently press for punitive measures to
deal with the drug problem.
Needle-exchange programs cannot proceed without the co-
operation of the very groups that traditionally oppose them-law
enforcers and community leaders. The conflict between public
health and criminal justice is well illustrated by the dilemmas
inherent in needle exchange: public health officials in some of the
highest seroprevalence cities cannot establish exchange programs
without first obtaining authorization from the state under needle-
prescription laws; the police must agree not to arrest and the
district attorney not to prosecute people using drug paraphernalia
distributed under the needle-exchange program; and community
leaders must agree to the location of needle distribution centers,
which, if they are to be effective, need to be situated in poor urban
areas. 
132
Forging political and social consensus around needle exchange
in the United States has been exceedingly difficult. The history of
needle exchange 3 3 is a story of political conflict and legal obstacles
that have delayed or stopped the establishment of effective ex-
change programs. In 1988 New York City Health Commissioner
Stephen Joseph expressed his frustration with the political and
legal delays: "We have lost so much time, and an enormous num-
ber of lives. '1 34
Needle-exchange programs that were strongly supported by
city public health departments were successfully blocked in Bos-
13 Cooperation is made more difficult by interagency conflict over needle-exchange
programs. Such conflict occurred on the federal level in 1989 when the U.S. Secretary for
Health and Human Services (HHS), Dr. Louis Sullivan, encouraged communities to estab-
lish needle exchange, even though the Justice Department and the Director of National
Drug Control Policy opposed such policies. See Incoming HHS Chief Backs Needle Ex-
change, Boston Globe, Mar. 9, 1989, at 1, col. 2. After pressure from the White House,
the HHS Secretary quickly withdrew his support. Kosterlitz, A Doctor in the Pulpit, 22
NAT'L JOURNAL 2466 (1990). Moreover, the Anti-Drug Abuse Act of 1988, 42 U.S.C.
§ 300x-3(c)(2)(a) (1988), specifically prohibits most federal funding of programs that distrib-
ute needles. Rep. Charles B. Rangel, Chair of the House Narcotics Committee, has said
that the justification for barring federal support for programs to distribute needles to IV
drug users is that free needles do little but prolong drug addiction. Rangel, Needle Ex-
changes Hurt the Fight Against Drugs, USA Today, Apr. 28, 1989, at 10A, col. 4.
3 Needle-exchange programs were proposed as early as 1986, when the Institute of
Medicine stated that "[i]t is time to begin experimenting with public policies to encourage
the use of sterile needles and syringes by removing legal and administrative barriers to
their possession and use." INSTITUTE OF MEDICINE, NATIONAL ACADEMY OF SCIENCES,
CONFRONTING AIDS: DIRECTIONS FOR PUBLIC HEALTH, HEALTH CARE, AND RESEARCH
110 (1986).
134 Wade, For Addicts: A Death Penalty, N.Y. Times, July 6, 1988, at A22, col. 1.
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ton, 135 San Francisco, 136 Los Angeles 137 and Chicago. 38 The na-
tion's first needle-exchange program, in New York City, experi-
enced significant problems in formation and operation. 139 The
Portland, Oregon needle-exchange program also initially experi-
enced problems. The program was less controversial than others
because it was run by a non-profit social services agency admin-
istering a grant from the American Foundation for AIDS Research.
In addition, the state already allowed over-the-counter sales of
hypodermic syringes and needles. Nonetheless, implementation of
the program was delayed because of the difficulty in obtaining
insurance and because of legal challenges to the program. In re-
sponding to political pressures, Portland's mayor stressed that the
program did not actually involve the city itself in the distribution
of injection equipment. 40 Needle-exchange programs have also
been established in Tacoma, Washington; 4' Boulder, Colorado; 42
and Hawaii. 143
" Bostonians Split on Mayor's Idea of Needle Swap, supra note 131; Legalize Syringe
Sales, Say Activists, Boston Globe, Mar. 20, 1989, at 19, col. 5.
136 Heilig, AIDS, Needles and Public Healtit: Difficult Choices, SAN FR, ANCISCO MED-
ICINE, March 1987, at 15.
137 Zonana, N.Y. Begins Giving Needles to Addicts in AIDS Battle, L.A. Times, Nov.
8, 1988, at 1, col. 5.
138 N.Y. Times, Jan. 30, 1989, at Al, col. 3; Dinkins to End Needle Plan for Drug
Users, N.Y. Times, Feb. 14, 1990, at BI, col. 5.
139 Merz, First Needle-Exchange Program Approved: Other Cities Await Results, 259
J.A.M.A. 1289 (1988).
1
40 Raymond, U.S. Cities Struggle to Implement Needle Exchanges Despite Apparent
Success in European Cities, 260 J.A.M.A. 2620 (1988); Addicts in Portland, Ore., Will Get
Free Hypodermic Needles, N.Y. Times, June 10, 1988, at A13, col. 1.
'4, See Gross, supra note 130. The legality of the Tacoma program was upheld in Allen
v. City of Tacoma, No. 89-2-09067-3 (Wash. Super. Ct., Pierce County, May 9, 1990). In
January 1989 the Tacoma County Board of Health voted to fund a needle-exchange pro-
gram. Gross, Needle Exchange for Addicts Wins Foothold Against AIDS in Tacoma, N.Y.
Times, Jan. 23, 1989, at A12, col. 4. In July 1989 the Attorney General for Washington
State issued an opinion that the program violated the state's drug-paraphernalia act, WASH.
REV. CODE § 69.50 (1985 & Supp. 1990). The County Public Health Commissioner filed
the Allen case seeking a declaratory judgment that the exchange program was lawful. The
Allen court held that the needle-exchange program does not violate the drug-paraphernalia
statute since that statute exempts government officials engaged in the lawful performance
of their duties from liability. WASH. REV. CODE § 69.50.506 (1985 & Supp. 1990). The court
also noted that Washington's AIDS law, WASH. REV. CODE § 70.24.400 (Supp. 1990),
authorizes locally developed public health programs designed to control the needle-borne
spread of AIDS. Allen, slip op. at 3-9.
142 Boulder County began a publicly funded needle-exchange program on Feb. 14, 1989.
The program is modeled after the Tacoma program, discussed supra note 128. Health
Department outreach workers visit homes and gathering places of IV drug users. SAN
FRANCISCO AIDS FOUNDATION, supra note 130, at 13.
,43 See 1990 Haw. Sess. Laws 280 §§ 2-4 (allowing a two-year pilot needle-exchange
program).
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a. Needle Exchange: The Unhappy Legacy of the New York
City Experience
In New York City the HIV seroprevalence is estimated to be
between fifty and sixty percent among the 200,000 IV drug users. 144
Proposals for a needle-exchange program in New York City were
put forth in 1985 and 1987 by successive city health commission-
ers. 145 Establishing a needle-exchange program in New York City
required permission by the state because the needle-prescription
law could be waived only by authority of the public health com-
missioner. 146 The state governor and public health department ini-
tially opposed the proposals ostensibly because they were scien-
tifically unsound. 147 However, on August 11, 1988 the state granted
a waiver under the statute for the demonstration project. Even
after announcement of the waiver, some local police officers, who
had opposed the program, expressed the view that the state had
no authority to waive the statutory requirement and vowed to
uphold the statute anyway.1 48
The New York project included an evaluation component and
a counseling requirement. Participants received a free sterile nee-
dle only during drug counseling sessions and could exchange the
needle at another session. Monitoring included an analysis of res-
idues on the needles turned in for the presence of more than one
blood type. Participants' entry into treatment was also
monitored.149
'44 INSTITUTE OF MEDICINE, NATIONAL ACADEMY OF SCIENCES, CONFRONTING AIDS:
UPDATE 84 (1988) [hereinafter CONFRONTING AIDS]; NEW YORK CITY DEPARTMENT OF
HEALTH, THE PILOT NEEDLE EXCHANGE STUDY IN NEw YORK CITY: A BRIDGE TO
TREATMENT 4 (1989) [hereinafter N.Y. DEP'T HEALTH, A BRIDGE TO TREATMENT].
14S See generally Joseph & Des Jarlais, Needle and Syringe Exchange as a Method of
AIDS Epidemic Control, AIDS UPDATE, Sept.-Oct. 1989, at 4.
'46 N.Y. PUB. HEALTH L. § 3381 (McKinney 1985); N.Y. PENAL L. § 220.45 (McKinney
1989).
14* The several hundred drug users included in the demonstration project were consid-
ered an insufficient sample. N.Y. State Rejects Plan to Give Drug Users Needles, N.Y.
Times, Mar. 17, 1987, § 1, at 38, col. 1. Yet, when the program was finally approved it still
had a study design consisting of needle distribution to only 200 persons. N.Y. Begins Giving
Needles to Addicts in AIDS Battle, L.A. Times, Nov. 8, 1988, § 1, at 1, col. 5; New York
to Begin Free-Needle Plan For Drug Addicts, N.Y. Times, Aug. 12, 1988, at Al, col. 4.
There were also strong protests from minority groups in the city. See Marriott, supra note
66.
148 Merz, supra note 139, at 1289.
"9 Drug Needle Exchange is Gaining but Still Under Fire, N.Y. Times, June 7, 1989,
at BI, col. 2.
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New York City's needle-exchange program did not actually
begin until November 1988. The public health department could
not gain local agreement for four proposed sites accessible to IV
drug users. The mayor acquiesced to neighborhood groups, de-
claring any site unsuitable if it was within 1000 feet of a school or
day care center. The program was, therefore, located in one site
only, the city Health Department itself. The Department is located
in the heart of the financial district, "confined to a former X-ray
clinic hardly larger than a one-car garage" and situated adjacent
to a city jail, the courts and central Police Headquarters.15
Two hundred and fifty persons were recruited and evaluated
in the New York City needle-exchange pilot program through
December 1, 1989.1-1 Fifty-one percent of the program population
was already infected with HIV. 152 The city health commissioner
strongly recommended the continuation and expansion of the pro-
gram based upon the results of the pilot study. 5 3 Even given the
methodological concerns in performing a rigorous scientific eval-
uation of needle-exchange programs, 154 the New York City pilot
program was highly successful.
First, the pilot program was effective in providing a bridge to
treatment. Seventy-eight percent of its clients accepted a referral
to treatment, including methadone maintenance and detoxifica-
tion. 155 Second, the program effectively utilized the increase in
personal contact between illicit drug users and health care workers
to provide an array of services. Program workers were successful
in identifying individuals in need of a variety of health and social
services including housing, primary health care, treatment for sex-
ually transmitted diseases and physical problems associated with
chronic drug use.156 These two results reinforce the notion that
increasing health care contact points will improve treatment ser-
vices for drug users, their sexual partners and their children.
,-o N.Y. Times, Jan. 30, 1989, at Al, col. 3.
1-1 Two-thirds were male; the mean age was 33.4 years; 27% were African American,
53% Hispanic, and 18% white; 14% had a temporary domicile and 32% were homeless.
N.Y. DEP'T OF HEALTH, A BRIDGE TO TREATMENT, supra note 144, at 10-11.
1S2 Id. at 10.
151 Id. at 18.
154 These concerns include the difficulty of constituting a reliable control group, the
reliability of self-reported changes in behavior, the unrepresentative nature of individuals
who volunteer for the program and who choose to make a return visit, and the small sample
size. Joseph & Des Jarlais, supra note 145, at 3-4.
155 N.Y. DEP'T HEALTH, A BRIDGE TO TREATMENT, supra note 144, at 11-12.
,56 Id. at 14.
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Another success of the syringe exchange program was reduc-
ing the incidence of sharing. Upon enrollment, 82% of the clients
reported sharing needles in their lifetime, with 62% reporting shar-
ing within the past thirty days. Only 5% of those clients who
revisited the exchange program reported sharing since their last
visit. 157 In other syringe programs, self-reported sharing behaviors
declined over time, with continued program participation. 58
The final success of the needle-exchange program was the
safe disposal of a large amount of potentially contaminated injec-
tion equipment. Sixty percent of the 110 enrollees who returned
for a second visit returned their needles.15 9 A syringe exchange
program permits disposal of dirty needles, rather than risking the
use of discarded, contaminated injection equipment by addicts not
participating in the program.
No definitive empirical data exist to support or detract from
the claim that needle-exchange programs encourage illicit drug
injection. Instead, the experience in New York and elsewhere
suggests that needle exchange can provide a bridge to treatment,
taking drug users off the streets and out of the drug demand cycle.
The experimental program in New York City was aborted by
the new mayor early in 1990 after only two years of operation.160
The program was terminated because it had too few enrollees. The
program's lack of enrollees is not surprising, however, considering
its inaccessibility to most of the city's drug users.
b. Bleach-Distribution Programs
Another way for the state to increase the supply of sterile
injection equipment is to distribute disinfectants to the drug-de-
157 Id. at 12-13. Self-reporting of sharing behaviors may be more reliable than blood-
type analysis of residue on the needles. Many syringes are returned clean enough that it is
impossible to detect any blood residue; moreover, many clients will have the same blood
type as those with whom they shared, thus blood-type detection will not reveal such
instances of sharing. For these reasons, an objective monitoring of returned syringes based
on blood types is "a crude measure at best." Id.
' Id. at 13.
"'Id. at 12.
160 Dinkins to End Needle Plan for Drug Users, N.Y. Times, Feb. 14, 1990, at B1, col.
5. A few months later the newly appointed Commissioner for Health in New York City
eliminated a city financed program that taught drug users how to avoid exposure to HIV
when injecting drugs. For example, the program instructed addicts in how to disinfect their
needles with bleach. Health Chief is Criticized on AIDS Shift, N.Y. Times, May 10, 1990,
at B1, col. 5. The Commissioner, Dr. Woodrow A. Myers, Jr., is also opposed to legalizing
the sale of needles without a prescription. Id.
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pendent population. Innovative programs that distribute vials of
bleach to encourage sterilization of works are already under way
in New York, 161 New Jersey 62 and San Francisco.163 Drug-depen-
dent persons are instructed to rinse their works with household
bleach and then twice with water so that traces of the bleach are
not injected.
The importance of actually distributing vials of bleach is illus-
trated by experiences with bleach programs in Baltimore.16' The
public health departments there distributed detailed information
about AIDS, including directions on how to sterilize needles and
syringes through boiling or the use of alcohol and bleach. Residents
of neighborhoods that participated in these outreach programs had
significantly greater knowledge of what constitutes dangerous be-
havior than those in neighborhoods that did not participate. Yet,
no significant differences were measured in the number of injec-
tions, sterilization, or sharing practices in the "knowledgeable"
neighborhoods.
The importance of providing an array of "means" to comply
with public health advice is reinforced by ethnographic studies of
behavior while in withdrawal. Withdrawal has been shown to be
a critical factor retarding safer injection practices. 65 The severe
physical discomfort and the craving for relief drives users to resort
to any readily available needle and syringe for injecting the drug.
Asking a drug-dependent person to prolong withdrawal in order to
obtain uncontaminated injection equipment virtually guarantees
failure in risk-reduction efforts. The design of public health pro-
grams must ensure that IV drug users have immediate, unimpeded
access to sterile equipment prior to the time of injection. Distrib-
uting vials of bleach, coupled with education about their proper
use, will achieve just that goal.
2. The Experience with Needle Exchange Abroad
Needle-exchange programs in other parts of the world have
not usually encountered the same political and public obstacles
161 Des Jarlais & Friedman, supra note 16, at 865-70.
162 Jackson, Rotkiewicz, Quinones & Passannate, A Coupon Program-Drug Treat-
ment and AIDS Education, 24 INT'L J. ADDICTION 1035, 1035-51 (1990).
163 Chaisson, Osmond, Moss, Feldman & Bemacki, HIV, Bleach, and Needle Sharing,
20 LANCET 5 (1987).
"6 McAuliffe, Breer & Doering, An Evaluation of Using Ex-Addict Outreach Workers
to Educate Intravenous Drug Users about AIDS, 4 AIDS & PUB. POL'Y J. 218 (1989).
165 See supra notes 35-37 and accompanying text.
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they face in the United States. 166 Many countries have been able
effectively to harmonize the objectives of law enforcement and
public health and have gained broad consensus for needle-ex-
change programs. 167 The World Health Organization has formed a
global working group to support needle-exchange and -distribution
programs. Outlets for sterile injection equipment have been estab-
lished in a number of countries in Western Europe'68 as well as in
Canada 69 and Australia. 170 Government sponsored research in
Australia,17 1 Great Britain1 72 and the Netherlands173 concluded that
the distribution projects were successful and made recommenda-
tions for their continuation. Preliminary results indicate that the
availability of sterile injection equipment has not increased drug
use. More significantly, these results also show some decline in
HIV seroprevalence rates. 174 The programs also tend to attract
individuals with no prior contact with drug treatment programs.
166 See generally Karpen, A Comprehensive World Overview of Needle Exchange
Programs, AIDS PATIENT CARE, Aug. 1990, at 26.
167 See Fox, Day & Klein, supra note 21.
168 See, e.g., infra notes 172, 173.
169 See Blatherwick, How to "Sell" a Needle Exchange Program, 80 CAN. J. PUB.
HEALTH 26 (1989). Vancouver initiated a multifaceted needle-exchange program in March
1989. As of the end of October 1989, about 2600 users had registered. The needle-exchange
rate increased steadily, reaching a peak of 93%. Bardsley, Turvey & Blatherwick, Vancou-
ver's Needle Exchange Program, 81 CAN. J. PUB. HEALTH 39 (1990).
, 0 SAN FRANcIsco AIDS FOUNDATION, supra note 130, at 20-24 (1989); Wodak,
Needle Exchange Succeeding in Australia, N.Y. Times, Mar. 26, 1990, at A16, col. 4.
171 Wolk, Wodak & Guinan, HIV Seroprevalence in Syringes of Intravenous Drug
Users Using Syringe Exchanges in Sydney, Australia, presented at the Fourth Int'l Conf.
on AIDS, Stockholm (June 1988) (reported in Des Jarlais, AIDS Prevention Programs for
Intravenous Drug Users: Diversity and Evolution, 1 INT'L REV. PSYCHIATRY 101, 102 n. 19
(1989)); see also Wolk, Wodak, Morlet, Guinan & Gold, HIV-Related Risk Taking Behavior,
Knowledge and Serostatus of Intravenous Drug Users in Sydney, 152 MED. J. AUSTL. 453
(1990).
172 Hart, Carvell, Woodward, Johnson, Williams & Parry, Evaluation of Needle Ex-
change in Central London: Behaviour Change and Anti-HIV Status Over One Year, 3
AIDS 261 (1989); see also Morrison & Plant, Drug Problems and Patterns of Service Use
Amongst Illicit Drug Users in Edinburgh, 85 BRIT. J. ADDICTION 547 (1990). See generally
Stimson, AIDS and HIV: The Challenge For British Drug Services, 85 BRIT. J. ADDICTION
329 (1990)
17 Buning, van Brussel & van Santen, Amsterdam's Drug Policy and Its Implications
for Controlling Needle Sharing, in NIDA MONOGRAPH No. 80, supra note 14, at 59 (1988).
,74 See Raymond, supra note 140, at 2621; Joseph & Des Jarlais, supra note 145, at 3-
4. Since 1984 a steadily increasing number of drug stores in Geneva has sold sterile injection
equipment. Robert, Deglon, Wintsch, Martin. Perrin, Bourquin, Garbriel & Hirschel, Be-
havioral Changes in Intravenous Drug Users in Geneva: Rise and Fall of HIV Infection,
1980-1989, 4 AIDS 657 (1990). A study of behavioral change in IV drug users showed that
HIV seroprevalence among IV drug users increased rapidly from 1981 to 1983 (from 6% to
38%) before the program was put in place. Since that time, needle sharing has decreased
dramatically, and the seroprevalence rate among IV drug users has actually diminished.
Id.
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a. The Netherlands
Amsterdam has approximately 3000 IV drug users. 75 As of
March 1988, only 4.7% of the cumulative total of reported AIDS
cases in Amsterdam involved individuals whose only risk factor
was drug use. 176 The needle-and-syringe-exchange program in Am-
sterdam began in the summer of 1984 through an initiative of the
"junkiebond," a league of drug users. The primary health concern
at the time was needle-borne transmission of hepatitis B. The
Municipal Health Service brought injection equipment to the jun-
kiebond, and collected the used needles for disposal; approxi-
mately 1200 syringes and needles were exchanged weekly. 77 The
number of needles distributed increased to 720,000 in 1988. There
are eleven distribution centers, consisting of drug organizations,
treatment centers and methadone buses. 178 Condoms and leaflets
on safer sex can also be obtained at needle-distribution centers.
An estimated 38% of all needles and syringes used by drug injec-
tors are obtained from exchange programs, and most of the rest
are bought in medical shops, pharmacies and other outlets.179
Many of the "harm reduction" objectives of the exchange
program have been met. First, the safe disposal of injection equip-
ment has increased over time: 70% of needles were returned in
1986, 86% in 1987, and 95% by September 1988.180 Second, bor-
rowing and lending injection equipment among current users de-
creased sharply over time: 56% reported such activity after the
first visit, 26% after the second visit, and 16% after the third
visit.' 8 1 Third, there was a sharp increase in the proportion of IV
175 See Des Jarlais, supra note 171, at 104.
176 GEMEENTELUKE GENEES KUNDIGE ENGEZUNDHEIDSDIENST AMSTERDAM, THE
AMSTERDAM MUNICIPAL HEALTH SERVICE AND THE AIDS-PROBLEM 1 (1988) [hereinafter
THE AMSTERDAM MUNICIPAL HEALTH SERVICE].
177 Buning, van Brussel & van Santen, Amsterdam's Drug Policy and Its Implications
for Controlling Needle Sharing, in NIDA MONOGRAPH No. 80, supra note 14, at 67-73
(1988).
178 Hartgers, Buning, van Santen, Verster & Coutinho, The Impact of the Needle and
Syringe-Exchange Programme in Amsterdam on Injecting Risk Behaviour, 3 AIDS 571,
(1989). See also Des Jarlais, supra note 171, at 103-04.
179 Hartgers, Buning, van Santen, Verster & Coutinho, supra note 178, at 572.
18o SAN FRANCISCO AIDS FOUNDATION, Needle Exchange in the United States and
Abroad, in NEEDLE EXCHANGE PROGRAMS 22 (1989); Hartgers, Buning, van Santen, Verster
& Coutinho, supra note 178, at 571.
181 van den Hoek, van Haastrecht & Coutinho, Risk Reduction Among Intravenous
Drug Users in Amsterdam Under the Influence of AIDS, 79 AM. J. PUB. HEALTH 1355,
1356 (1989).
Drug Dependency and AIDS
drug users making exclusive use of the exchange program to obtain
sterile injection equipment: from 13% after the first intake period
to 66.7% after the fourth intake period. 182 The number of IV drug
users followed in longitudinal studies is too low to examine accu-
rately the HIV seroconversion rates. However, the percentage of
IV drug users among reported AIDS cases in Amsterdam is much
lower than the corresponding percentage in the United States,
which has failed to adopt many large-scale needle-exchange pro-
grams. 183 Finally, researchers, unable to find any evidence that
non-IV drug users in the study groups started intravenous use as
a consequence of the availability of sterile equipment, concluded
"that the Amsterdam AIDS prevention campaign did not increase
the intravenous use of drugs. . .."184
b. United Kingdom
The percentage of AIDS cases attributable to IV drug use in
the United Kingdom (16%) 185 is somewhat lower than that in the
United States (29%).186 In the U.K., as in the United States, there
is substantial evidence that needle sharing has been common
among IV drug users.187 In response to this problem, the British
government established fifteen pilot needle exchanges in April
1987. 188
The report on the pilot needle-exchange programs indicated
they had reached clients who had not previously been in contact
with drug treatment services. 8 9 A primary goal, then, was to offer
11 2d. at 1356-57.
83 Compare the 4.7% of cumulative AIDS cases in Amsterdam, THE AMSTERDAM
MUNICIPAL HEALTH SERVICE, supra note 176, at 1, with the 19% in the United States
through September 1990, CENTERS FOR DISEASE CONTROL, SEPT. 1990, supra note 11, at
15.
18 van den Hoek, van Haastrecht & Coutinho, supra note 181, at 1357; see also
Ginzburg, Needle Exchange Programs: A Medical or a Policy Dilemma?, 79 AM. J. PuB.
HEALTH 1350 (1989); Hartgers, Buning, van Santen, Verster & Coutinho, supra note 178.
1815 Farid, AIDS and Drug Addiction Needle Exchange Schemes: A Step in the Dark,
81 J. ROYAL SOC. MED. 375 (1988).
18 CENTERS FOR DISEASE CONTROL, SEPT. 1990, supra note 11, at 15.
187 See, e.g., Mulleady & Green, Syringe Sharing Among London Drug Abusers, 2
LANCET 1425 (1985); Robertson, Bucknell, Welsby, Roberts, Inglis, Peutherer & Brettle,
supra note 12.
288 Glanz, Drug Misuse and AIDS Prevention: Policy on the Right Track, 83 BRIT. J.
ADDICTION 1237 (1988); Stimson, Alldritt, Dolan & Donoghoe, Syringe Exchange Schemes
for Drug Users in England and Scotland, 296 BRIT. MED. J. 1717, 1718 (1988).
289 See Stimson, Alldritt, Dolan & Donoghoe, supra note 188, at 1718 (noting that 31%
of the clients at the pilot needle-exchange programs had received no previous drug
treatment).
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treatment, counseling and education services. Clients of needle-
exchange programs reported less frequent needle sharing than
other IV drug users, but this may be attributed to self-selection.
The greatest problem with the pilot programs was the high attrition
rate, with 61% staying for a second visit and only 17% for a tenth
visit.190 To attract more clients and keep them, the Liverpool
exchange scheme is not routinely offering counseling and treat-
ment referral. 191 The English experience suggests that there may
be a trade-off between attracting and keeping clients and providing
a full range of health and social services. 92
c. Australia
Although the HIV incidence rate in Australia is among the
highest in the world, there has been a low seroprevalence rate
among IV drug users.193 Only 4.6% of the cumulative total of AIDS
cases in Australia involve individuals whose only high-risk behav-
ior is IV drug use.194
A syringe exchange program was established in New South
Wales (NSW), Australia in December 1986. The NSW government
amended existing legislation that had prohibited the sale and pos-
session of drug-injection equipment. The exchange program is
190 G. STIMSON, INJECTING EQUIPMENT EXCHANGE SCHEMES 5 (1988) (Final Report,
Monitoring Research Group, University of London, Goldsmith's College). Recent evalua-
tions of the London program showed high rates of referral to drug treatment programs,
particularly among clients who had long histories of drug use and very little contact with
the public health care system. See Carvell & Hart, Help-Seeking and Referrals in a Needle
Exchange: A Comprehensive Service to Injecting Drug Users, 85 BRIT. J. ADDICTION 235
(1990); Stimson, Dolan, Donoghoe & Lart, The Pilot Syringe Exchange Project in England
and Scotland-A Summary of Evaluation, 84 BRIT. J. ADDICTION 1283 (1989).
191 Lohr, supra note 116.
'92 In an effort to increase attendance and compliance, one exchange facility in London
has an "open access" policy. The facility eschews rigorous eligibility requirements and
detailed interviewing about commitment to abstinence oriented treatment. Hart, Woodward
& Carvell, Needle-Exchange in CentralLondon: Operating Philosophy and Communication
Strategies, I AIDS CARE 125, 129-30 (1989).
193 See Blacker, Tindall, Wodak & Cooper, Exposure of Intravenous Drug Users to
AIDS Retrovirus, Sydney 1985, 16 AUSTL. & N.Z. J. MED. 686 (1986) (only one HIV-
positive person found among 200 IV drug users at five Sydney drug referral and treatment
centers).
11 Wodak & Whyte, AIDS and Intravenous Drug Users in Australia, 2 AIDS LAW &
POLICY J. 47 (1989). This compares with 19% in the United States, CENTERS FOR DISEASE
CONTROL, SEPT. 1990, supra note 11, at 15, and 64% in Italy. WORLD HEALTH ORGANI-
ZATION COLLABORATING CENTRE ON AIDS, Q. REP. No. 20, AIDS SURVEILLANCE IN
EUROPE (Dec. 31, 1988).
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carried out by a network of pharmacies throughout the state. 195
Pharmacists actively participate in the program and display favor-
able attitudes toward it. 196
Those who have studied the NSW exchange program have
recommended its continuation, and have concluded that it was
successful in meeting its goals of removing contaminated syringes
from circulation, referring people into treatment, and reducing
needle sharing. 197
3. Evaluation of Needle-Exchange Programs: Meeting Valid
Public Health Objectives
Preliminary data show that needle exchange, in conjunction
with other strategies, could be an effective public health policy 198
to slow the drug and HIV epidemics. 199 Perhaps the most promising
aspect of the various studies is the indication of the potential value
of needle exchange as a bridge to drug treatment and to a wide
array of other health and social services. 200 Although drug users
often have pressing health and welfare needs, they are exceedingly
difficult to reach. Offering a benefit to drug users facilitates positive
contact with them. Using needle exchange as a way to offer drug
users HIV testing, counseling, sex education, treatment referrals,
195 Tsai, Goh, Welbeck & Mullins, Prevention of Human Immunodeficiency Virus
Infection Among Intravenous Drug Users in New South Wales, Australia: The Needles
and Syringes Distribution Programme Through Retail Pharmacies, 2 AsIA-PACIFIC J. PUB.
HEALTH 245 (1988).
19 Id.
197 Wodak, Dolan, Imrie, Gold, Wolk, Whyte & Cooper, Antibodies to Human Im-
munodeficiency Virus in Needles and Syringes Used by Intravenous Drug Abusers, 147
MED. J. AUSTL. 275 (1987); Wodak, Needle Exchange Succeeding in Australia, N.Y. Times,
Mar. 26, 1989, at A16, col. 4; Wodak & Penny, A Report of the National Advisory
Committee on Acquired Immunodeficiency Syndrome's Workshop on Human Immunode-
ficiency Virus Infection and Intravenous Drug Abuse, 149 MED. J. AUSTL. 373 (1988).
19a See generally Wood, Needle Exchange Programs Stop AIDS!, 4 AIDS PATIENT
CARE 14 (1990).
,99 Admittedly, the data collected from needle-exchange programs in the United States
and abroad are decidedly insufficient because of small sample size and methodological
concerns. See supra notes 151-154 and accompanying text. Comparative research is also
difficult to evaluate, since data from one country are not necessarily transferable to another
culture. Still, the urgency associated with drug use and the needle-borne transmission of
infectious disease suggests that programs that show some promise of being effective ought
to be more carefully evaluated.
2w See supra notes 155-156 and accompanying text.
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housing and social support is well worth the moderate cost of
exchange programs*201
However, exchange programs that thrust services on clients
have difficulty attracting and keeping clients.20 2 Programs that
"don't preach" and only distribute needles have lower client attri-
tion.203 To be sure, it is difficult to attract and keep illicit drug
users within any traditional public health program. Nonetheless,
it makes little sense to give up a major benefit of the program in
order to attract clients. Instead, exchange programs should be
designed and advertized with the user in mind: they should operate
out of convenient and non-threatening locations; the staff should
be attuned to the drug culture; the services should be offered in a
non-coercive rather than compulsory manner; the programs should
be confidential; and non-discrimination on the basis of HIV infec-
tion should be the norm.2 04
An explicit goal of exchange programs is reducing the inci-
dence of needle sharing. Data show that the longer the user attends
exchange programs the more likely he is to report significant re-
ductions in sharing behavior.20 5 Moreover, the longer the client
attends the more likely it is that the exchange program will be his
exclusive source of injection equipment.2 6 The incidence of nee-
dle-borne transmission will be reduced if users alter their usual
sharing behavior and rely upon public health programs instead of
dealers and shooting gallery proprietors for their works. Evidence
of reduced sharing suggests that drug users are aware of AIDS
risks, concerned about their health and willing to alter their be-
havior to avoid needle-borne infections.207
201 The cost for operating the New York City Pilot Program for 10 months was $178,370.
The pilot program served 294 persons, with a further 61 in a comparison group. N.Y. DEP'T
HEALTH, A BRIDGE TO TREATMENT, supra note 144, at 10. This compares with a cost of
between $25,000 and $60,000 per case for treating a person with AIDS, and approximately
$3,000 per patient per year for drug treatment. See INSTITUTE OF MEDICINE, supra note
133, at 12; Fox & Thomas, The Cost of AIDS: Exaggeration, Entitlement, and Economics,
in AIDS AND THE HEALTH CARE SYSTEM 197 (L. Gostin ed. 1990).
202 See supra notes 191-192 and accompanying text.
201 Lohr, supra note 116.
204 In Doe v. Centinela Hospital, 57 U.S.L.W. 2034 (C.D. Cal. 1988), for example, a
federally funded drug treatment program refused to admit a person because he was infected
with HIV. The court held that this action violated section 504 of the Rehabilitation Act of
1973. 29 U.S.C. § 794 (1988). See Gostin, The AIDS Litigation Project: A National Review
of Court and Human Rights Commission Decisions, Part 1I: Discrimination, 263 J. A.M.A.
2086, 2089 (1990).
205 See supra notes 157-158 and accompanying text.
206 See supra note 182 and accompanying text.
207 See supra notes 43-45 and accompanying text.
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It is extraordinarily difficult to demonstrate that reduced HIV
seroprevalence rates are due to the establishment of needle-ex-
change programs. So many factors affect the rate of HIV trans-
mission that the effect of one cannot be scientifically measured.
Nevertheless, widespread sharing in cities with tight restrictions
on needle supply has been linked to the disproportionately high
prevalence of HIV in those cities. 2 8 HIV seroprevalence rates are
lowef' in cities that make sterile injection equipment more readily
available, such as Amsterdam. 2 9 While these figures establish no
definite causal link between limits on sterile injection equipment
and the HIV seroprevalence rate, they do indicate that supply
limitations are not decreasing seroprevalence rates and that readily
accessible supplies are not resulting in a feared increase in HIV
infection. 210
An important advantage exchange programs have over pro-
grams that simply distribute injection equipment is that they reduce
the supply of contaminated needles in circulation. More estab-
lished programs such as the one in Amsterdam have experienced
excellent rates of one-for-one exchanges. 211
Needle-exchange programs do not cause the various harms
feared by their opponents. 212 Government sponsored researchers
in the United States and abroad have concluded that there is no
measurable increase in drug use associated with needle ex-
change.21 3 Drug users who participate in exchange programs have
demonstrated either the same or lower rates of drug injection as
other drug users over the same time periods.2 1 4 Longitudinal stud-
ies of programs such as the Amsterdam exchange could detect no
increase in drug injection over time.215 Indeed, one study showed
no increase in the rate of drug injection in clients at a methadone
clinic that operated adjacent to the needle-exchange program.2 1 6
2 For example, New York has both needle-prescription and drug-paraphernalia laws
and a seroprevalence rate among IV drug users of from 50 to 60%. See supra note 144 and
accompanying text.
209 See THE AMSTERDAM MUNICIPAL HEALTH SERVICE, supra note 176.
210 See generally Des Jarlais, AIDS Prevention Programs for Intravenous Drug Users:
Diversity and Evolution, 1 INT'L REV. OF PSYCHIATRY 101, 102 (1989).
211 See supra notes 180-182 and accompanying text.
232 O'Brian, Needle Exchange Programs: Ethical and Policy Issues, 4 AIDS & PUB.
POL'Y J. 75, 79 (1989).
213 See supra note 174 and accompanying text.
214 See Joseph & Des Jarlais, supra note 145.
215 See supra note 184 and accompanying text.
216 See Wodak, Needle Exchange Succeeding in Australia, supra note 170.
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A person who has not injected drugs would be unlikely to do
so simply because of the operation of a government sponsored
exchange program. At most programs, a person cannot obtain
equipment unless he has demonstrated that he is an intravenous
drug user and has a used needle to exchange. 217 In any event, new
recruits into drug use can readily obtain injection equipment from
the dealer. Moreover, if exchange programs succeed in referring
clients for treatment who have not previously been accessible to
the public health community, their net impact is favorable to anti-
drug efforts.
The concern that needle-exchange programs appear to sanc-
tion an unlawful and unhealthy activity, particularly in vulnerable
minority areas already ravaged by the drug epidemic, could be
addressed through the dissemination of culturally appropriate anti-
drug messages at exchange centers. These messages should stress
that exchange programs are designed to help drug users reduce
their dependence through counseling and treatment. A more dif-
ficult problem with needle-exchange programs is that they may be
thrust on local communities without consultation and without a
comprehensive strategy for combatting drug abuse. Needle-ex-
change programs would be more palatable to those communities
as part of a comprehensive and well-funded package of services-
education, drug treatment and health care-designed to interrupt
the cycle of poverty, drug use and AIDS.
III. Providing Treatment to Confront the Dual Epidemics of
Drug Dependency and AIDS
A thirty-four-year-old crack addict from the South Bronx de-
cided he wanted to get well. After being turned away from nu-
merous treatment clinics and hospitals, he gave up on the health
care and drug treatment systems, and sought treatment through
the criminal justice system. He smashed windows in two police
stations and displayed a hypodermic syringe and a crack vial in a
third, only to find himself back on the streets.21 8 His efforts to be
217 "None of the exchanges has reported a person who had not previously injected
coming to a syringe exchange." Joseph & Des Jarlais, supra note 145, at 4.
218 Lambert, Fight in War of Drugs and AIDS, N.Y. Times, Dec. 23, 1988, at BI (city
ed.); see also N.Y. Times, Jan. 10, 1990, at Al, col. 5 (crack addict moved in with his
sister because of the absence of treatment. He spent four months indoors, afraid to face
the temptation of the streets).
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arrested were unavailing. This user's experience in New York City
reflects conditions in two-thirds of America's large urban areas,
where there are waiting lists of up to six months or more for drug
treatment programs2 19
Delays in providing treatment for IV drug users cost human
lives and scarce health care dollars. Drug dependency contributes
substantially to the spread of AIDS. A drug user who is turned
away from treatment will in all probability continue the dangerous
cycle of drug dependency, needle sharing, crime and prison. Im-
prisonment does not address the problem: -when the user is re-
leased from prison, the cycle will probably repeat itself.220 The
result is an ever increasing spiral of drug use, violence and HIV
infection. Moreover, society may have lost any opportunity to
recruit the user into treatment.
The lifestyles of drug-dependent people often drive them to
seek immediate relief from the physical and psychological effects
of drugs. A user cannot be relied upon to reappear for a treatment
slot that becomes available at some future time. For this reason,
the goal of public health must be treatment on demand. 221
Provision of treatment services does not generate the same
political conflicts as other strategies for confronting drug depen-
dency and AIDS. Public health and law enforcement agencies can
reach a consensus on drug treatment because it aims to reduce or
eliminate the injection of illicit drugs. The public health goal of
treatment, therefore, is consistent with prevailing moral values
and criminal proscriptions.
Despite the profound public health benefits of drug treatment,
and the agreement among the criminal justice and health care
systems, existing treatment services are inadequate. The govern-
ment and the public apparently undervalue rehabilitation as a pol-
icy option because of the belief that "treatment does not work. '222
219 The Institute of Medicine heard "dramatic testimony about users willing to sign up
for treatment such as methadone maintenance, only to be told of waiting periods of months."
INSTITUTE OF MEDICINE, supra note 133, at 108-09; see CONFRONTING AIDS, supra note
144, at 84-85; REPORT OF THE PRESIDENTIAL COMMISSION, supra note 18, at 96.
'2 See generally MAJORITY STAFFS OF THE SENATE JUDICIARY COMMITTEE AND THE
INTERNATIONAL NARCOTICS CONTROL CAUCUS, FIGHTING DRUG ABUSE: A NATIONAL
STRATEGY 66-71 (1990).
221 See, e.g., REPORT OF THE PRESIDENTIAL COMMISSION, supra note 18, at 94-104.
2n Criticism and calls for rejection of correctional treatment programs peaked in 1974
with the publication of a review of 231 treatment evaluation studies between 1945 and 1967.
This review concluded that treatment does not significantly reduce drug use or recidivism,
and asked, "Does nothing work?" Martinson, What works?-Questions and Answers About
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This insupportable perception is based upon outdated and inac-
curate scientific studies, the poor performance of treatment pro-
grams that did not possess an adequate number of experienced
personnel, and the absence of sufficient funding and commitment
to make the programs work.2 23 Moreover, asking the question
"Does treatment work?" is an overly simplistic approach to ana-
lyzing the benefits of treatment because many variables affect the
process and ultimate outcomes of treatment. 2 4 A more appropriate
question is whether treatment can work, if properly conceived,
funded and administered.
A. Can Treatment Work?
1. Treatment Evaluation Studies: Achieving Enduring
Reductions in Drug Use and Criminality
One explanation for the low level of funding and community
support for drug treatment is the common view that drug depen-
dency is a chronic, relapsing illness that is resistant to treatment.
Yet, a great deal of evaluative research demonstrates the efficacy
of treatment in reducing drug use, needle sharing and criminality,
and in increasing employment and social adjustment. 225 Further,
the longer the treatment process, the more likely that it will be
Prison Reform, 35 PUB. INTEREST 48 (1974); see NATIONAL CRIMINAL JUSTICE Ass'N,
U.S. DEP'T. OF JUSTICE, TREATMENT OPTIONS FOR DRUG-DEPENDENT OFFENDERS: A
REVIEW OF THE LITERATURE FOR STATE AND LOCAL DECISIONMAKERS 9-10 (1990) [here-
inafter TREATMENT OPTIONS].
22 Even Martinson renounced his position that "nothing works" based upon more
recent evaluations of 555 treatment programs: "Contrary to my previous position, some
treatment programs do have an appreciable effect on recidivism. Some programs are indeed
beneficial. New evidence from our study leads me to reject my original conclusion. I have
hesitated up to now, but the evidence in our survey is simply too overwhelming to ignore."
Martinson, New Findings, New Views: A Note of Caution Regarding Sentencing Reform,
7 HOFSTRA L. REV. 252-54 (1979).
224 Jerome Jaffe writes: "They will continue to ask, 'Does treatment work?' They may
be annoyed when they are told that the question can no longer be put in such simple
terms." Jaffe, Evaluating Drug Abuse Treatment: A Comment on the State of the Art, in
NATIONAL INSTITUTE ON DRUG ABUSE, U.S. DEPARTMENT OF HEALTH AND HUMAN
SERVICES, NIDA MONOGRAPH No. 51, DRUG ABUSE TREATMENT EVALUATION: STRATE-
GIES, PROGRESS, AND PROSPECTS 20 (1984 & reprint 1986, 1988) [hereinafter NIDA MON-
OGRAPH No. 51].
m See TREATMENT OPTIONS, supra note 222, at 2-5 ("[dlrug experts and criminaljustice practitioners almost universally agree that reducing the demand for drugs through
prevention and treatment holds the greatest hope for controlling drug abuse. Because
prevention is not a viable option for an already addicted offender, treatment is the only
vehicle for breaking the cycle of addiction and crime for such an individual.").
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effective in ameliorating the profound physical, psychological and
social problems of drug-dependency.
Two major evaluative research projects have led social sci-
entists to the nearly unanimous conclusion that treatment works:
the Treatment Outcome Prospective Study ("TOPS")226 and the
National Treatment System Based on the Drug Abuse Reporting
Program ("DARP").227 The TOPS project was a longitudinal study
of 11,750 people admitted to thirty-seven treatment programs in
ten cities from 1979 to 1981. The treatment modalities studied were
methadone maintenance, residential therapeutic treatment (thera-
peutic community treatment) and out-patient detoxification treat-
ment. The participants were tracked for five years.
The TOPS study showed that each of the treatment modalities
was effective in causing significant and enduring declines in drug
use. Overall fewer than 20% of the participants in any modality
were regular users of the drugs studied three to five years after
entering treatment. These effects were evident for non-opioid228 as
well as opioid 229 drugs. Even under the most rigorous outcome
standard, abstinence from cocaine, the treatment was successful.
Abstinence rates in the year after treatment ranged from between
40 to 47% among the three treatment modalities. 2 0 The Drug
Abuse Report Program, conducted before TOPS, involved almost
44,000 admissions to treatment. Similar abstinence and improve-
ment rates were found in the DARP study.231
22 6 R. HUBBARD, M. MARSDEN, J. RACHAL, H. HARWOOD, E. CAVANAUGH & H.
GINZBURG, DRUG ABUSE TREATMENT: A NATIONAL STUDY OF EFFECTIVENESS (1989)
[hereinafter The TOPS Study].
227 The primary source for the DARP study is found in THE EFFECTIVENESS OF DRUG
ABUSE TREATMENT: EVALUATION OF TREATMENT OUTCOMES FOR 1971-1972 DARP AD-
MISSION COHORT (S. Sells & D. Simpson eds. 1976) [hereinafter DARP]. One important
caveat, however, is that neither TOPS nor DARP were controlled trials. Controlled trials
to evaluate drug treatment outcomes are badly needed.
"2 "Three to five years after treatment, the percentage of regular cocaine users was 6-
16% in any of the modalities." Abstinence rates in the year after treatment were 40%
(methadone), 42% (out-patient/drug-free), and 47% (residential). The TOPS Study, supra
note 226, at 108-09.
2,9 Regular heroin use also declined among participants studied three to five years after
treatment: methadone (63.5% to 17.5%); residential (31.9% to 11.8%), and outpatient/drug-
free (from 8.6% to 4.6%). Id. at 102-03. The TOPS study did not find the same levels of
reduction in regular marijuana use. Id. at 117.
230 "Reductions in prevalence [of heroin use] were most dramatic for clients in outpa-
tient methadone and residential programs." Id. at 103. Otherwise, few significant differences
were detected based upon the modality of treatment, and no clear understanding emerged
about why treatment is effective. Id. at 102-21.
231 See generally Simpson, National Treatment System Evaluation Based on the Drug
Abuse Reporting Program (DARP) Followup Research, in NIDA MONOGRAPH No. 51,
supra note 224, at 29.
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Numerous smaller studies have repeatedly re-affirmed the
findings of TOPS and DARP: treatment is effective in reducing
drug use; treatment's effectiveness increases with duration; and
treatment achieves results that endure over time. The research
literature has focused upon treatment for opioid use because it
was the drug of choice. 232 However, non-opioid drugs, particularly
injectable and crack cocaine have emerged as the most frequently
used drugs in the late 1980s and the early part of this decade. 233
Treatment and program evaluation of cocaine use has been less
rigorous than for opioid drugs. Nevertheless, some studies have
reported similar levels of treatment efficacy for cocaine abuse. 234
In addition to reducing drug use, treatment reduces crime.
The association between drug use and crime is inescapable. Many
drug-dependent people commit their crimes as a means of obtain-
ing money to purchase their drugs. 235 Jails, courts and prosecutors
in major urban areas are overloaded with drug-dependent offend-
ers. However, because of case overload, most offenders receive
little or no prison time and no treatment. 236 Social scientists almost
universally report that reducing demand for drugs through preven-
tion and treatment reduces the level of drug-related criminal activ-
ity. Both the TOPS237 and DARP238 studies concluded that treat-
ment produces a dramatic decrease in criminal behavior.
TOPS, DARP and the host of smaller studies point to the
conclusion that treatment can work. Convincing policymakers and
232 See, e.g., NATIONAL INSTITUTE ON DRUG ABUSE, U.S. DEPARTMENT OF HEALTH
AND HUMAN SERVICES, NIDA MONOGRAPH No. ADM 83-1281, RESEARCH ON THE TREAT-
MENT OF NARCOTIC ADDICTION: STATE OF THE ART (1983) [hereinafter NIDA MONOGRAPH
No. ADM 83-1281]; Simpson & Savage, Drug Abuse Treatment Readmissions and Out-
comes, 37 ARCHIVES GEN. PSYCHIATRY 896 (1980).
23 See NATIONAL INSTITUTE ON DRUG ABUSE, supra note 24, at 29-39; N.Y. Times,
May 11, 1990, at A18, col. 5 (Senate Judiciary Report estimates nearly 2.2 million Americans
use cocaine each week).
234 See, e.g., Simpson, Joe, Lehman & Sells, Addiction Careers: Etiology, Treatment,
and 12-year Follow-up Outcomes, 16 J. DRUG ISSUES 107 (1986) (38% of opioid users used
cocaine before treatment, 18-22% used it one to six years after treatment, but 399 used it
in the 12th year after treatment, possibly because of the increased popularity of the drug).
2- Greenberg & Adler, Crime and Addiction: An Empirical Analysis of the Literature,
1920-1973, 3 CONTEMP. DRUG PROBS. 221 (1974); TREATMENT OPTIONS, supra note 222 at
1-2. See also TOPS, supra note 226 at 1, 152, and ch. 6.
236 TREATMENT OPTIONS, supra note 222, at 1; U.S. GENERAL ACCOUNTING OFFICE,
CONTROLLING DRUG ABUSE: A STATUS REPORT 19 (1988).
237 TOPS found that three to five years after leaving treatment, the proportion of clients
involved in predatory crimes was one-third to one-half of the pre-treatment level. The
TOPS Study, supra note 226, at 128.
31 See Simpson, supra note 231, at 31-33.
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the general public of this fact is the next important step towards
ensuring that treatment programs receive the attention and funding
they deserve.
2. Methadone Maintenance Programs
Methadone hydrochloride maintenance is a prime modality of
the drug treatment system.239 Methadone hydrochloride given to
heroin addicts at clinically appropriate daily doses blocks the ef-
fects of the drug so that withdrawal cravings are reduced or
eliminated.2 40
Methadone maintenance has been exhaustively studied and
has been demonstrated to be safe241 and effective. 242 Intravenous
drug abusers achieve immediate and substantial reductions in her-
oin use while on methadone maintenance. Studies have shown that
a significant percentage of drug users abstain from illicit opiate use
while in treatment.2 43 Positive effects are strengthened the longer
the person remains in the maintenance program.244
Methadone treatment has features that make it particularly
effective in impeding the needle-borne spread of HIV.2 45 It has the
29 Naltrexone and buprenorphine are two other drugs that are used for the treatment
of opioid addiction. Naltrexone is a long-acting competitive antagonist at opioid receptors
that blocks the responses produced by intravenous use of heroin. See Gonzalez & Brogden,
Naltrexone: A Review of its Pharmacodynamic and Pharmacokinetic Properties and Ther-
apeutic Efficacy in the Management of Opioid Dependence, 35 DRUGS 192 (1988). Bupren-
orphine has also been shown to control opioid use. See Goodwin, Buprenorphine May Be
Therapeutic Alternative for Opiate Addiction, 263 J. A.M.A. 2725 (1990); Kosten & Kleber,
Buprenorphine Detoxification from Opioid Dependence: A Pilot Study, 42 LIFE SCIENCE
635 (1988). As to the benefits of buprenorphine for non-opioid addiction, see infra note
253.
240 Clinical success in rehabilitation of heroin addicts with maintenance treatment re-
quires stability of the blood level in a pharmacologically effective range, optimally, 150 to
600 ng/mL. The molecular biological explanation for the effects of methadone are uncertain,
but effects have been consistently demonstrated by empirical research. See Dole, Impli-
cations of Methadone Maintenance for Theories of Narcotic Addiction, 260 J. A.M.A. 3025
(1988).
2A The safety of methadone when administered by competent health care professionals
in clinically indicated doses is beyond doubt. See Cooper, Methadone Treatment and
Acquired Immunodeficiency Syndrome, 262 J. AM. MED. A. 1664 (1989); Kreek, Health
Consequences Associated with the Use of Methadone, in NIDA MONOGRAPH No. ADM
83-1281, supra note 232, at 456.
72 See Cooper, supra note 241; see also The TOPS Study, supra note 226, at 5.
'A See McLellan, Luborsky, O'Brien, Woody, & Druley, Is Treatment for Substance
Abuse Effective? 247 J. A.M.A. 1423 (1982).
244 See Simpson, supra note 231, at 33.
US See Cooper, supra note 241, at 1664; Dole, Methadone Treatment and the Acquired
Immunodeficiency Syndrome Epidemic, 262 J. A.M.A. 1681 (1989).
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highest client retention rate of all of the treatment modalities.24 6
Client retention is important because length of treatment is one of
the best predictors of successful outcome. 247 Methadone treatment
also lowers risk behavior for HIV transmission by significantly
reducing the number of injections and the sharing of injection
equipment. Although reductions in injections and sharing are evi-
dent across the range of treatment modalities, methadone main-
tenance has the most pronounced effect.248 HIV seropositivity of
addicts enrolled in methadone maintenance is also consistently
lower than that of addicts not in treatment. 249
Despite the overwhelming evidence of methadone's ability to
combat the dual epidemics of AIDS and drugs, such programs
remain highly controversial. The concerns of opponents of meth-
adone expansion are not well articulated, but can be grouped into
three categories: methadone merely substitutes one long-term ad-
diction for another;250 methadone clients suffer from prejudice and
are viewed as dangerous and anti-social; 251 and methadone treat-
ment is itself immoral because of society's expressed preference
for a drug-free lifestyle. 2
These essentially ideological objections to methadone main-
tenance are hardly powerful given the practical effectiveness of
the drug. We may be bewildered by the chemical reasons why the
body seems to adapt so well to the long-term narcotic effects of
methadone,253 and we may prefer, both morally and socially, a
246 See Joe & Simpson, Retention in Treatment of Drug Users: 1971-1972 DARP
Admissions, 2 AM. J. DRUG & ALCOHOL ABUSE 63 (1975); Cooper, supra note 241, at 1664.
247 Within the first three months of treatment, only 14% of new methadone patients
drop out, while 40-50% drop out in other modalities. Id.
248 See Ball, Lange, Myers & Friedman, Reducing the Risk of AIDS Through Metha-
done Maintenance Treatment, 29 J. HEALTH & Soc. BEHAV. 214 (1988).
2A9 See Cooper, supra note 241, at 1665.
250 D'Amico, Methadone Treatment and Acquired Immunodeficiency Syndrome, 263
J. A.M.A. 658 (1990); see Kim, Methadone Maintenance Treatment Remains Controversial
Even After 23 Years of Experience, 260 J. A.M.A. 2970 (1988).
2' See Senay, Methadone Maintenance Treatment, 20 INT'L J. ADDICTION 803 (1985).
252 Rosenthal, Methadone Clone: A Bad Quick Fix, N.Y. Times, July 1, 1989, at 23,
col. 2. See Cooper, supra note 241, at 1665.
251 Perhaps the major drawback to methadone is that it is effective only in blocking
opioids. Cocaine is now surpassing heroin as the drug of choice and is fanning the flames
of the HIV epidemic. There are no FDA-approved chemical treatments for cocaine depen-
dence. There is, however, experimental evidence that buprenorphine suppresses the craving
for cocaine. Because buprenorphine is already recognized as safe and effective pharma-
cotherapy for heroin dependence, buprenorphine treatment may also one day be used to
attenuate dual abuse of cocaine and heroin. Mello, Mendelson, Bree & Lukas, Buprenor-
phine Suppresses Cocaine Self-Administration by Rhesus Monkeys, 245 SCIENCE 859 (1989).
Buprenorphine is a pain reliever that, "like methadone, induces a generalized feeling of
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person who is drug-free. Yet, few public health interventions have
been demonstrated to be as effective and safe as methadone. Sub-
stantial expansion of methadone maintenance would be a potent
tool for reducing drug abuse, crime and HIV transmission.
3. Compulsory Versus Voluntary Treatment
Drug treatment professionals understandably have been reluc-
tant to recommend compulsory interventions when there are long
waiting lists for persons actively seeking treatment. 2 4 Compulsory
intervention also contravenes the intuition that drug-dependent
people must be self-motivated in order to benefit from treatment. 255
This intuition, however, simply is not borne out by the relevant
data. In fact, there appears to be little difference in the efficacy of
treatment between those who volunteer for it and those who are
coerced into it.25 6
Compulsory treatment for drug abuse can be accomplished
through civil commitment or through the criminal justice system.
contentment rather than heroin's precipitate rush and euphoria. It is at least as effective
as methadone in easing physical withdrawal and reducing cravings, and it is significantly
more potent in blocking heroin's high if the addict tries to shoot up again. Unlike metha-
done, buprenorphine is relatively non addictive and carries almost no risk of overdose."
Purvis, Can Drugs Cure Drug Addiction?, TIME, Dec. 11, 1989, at 104; see also Kosten &
Kleber, Buprenorphine Detoxification from Opioid Dependence: A Pilot Study, 42 LIFE
SCIENCES 635 (1988).
24 A panel of drug abuse treatment professionals met under the auspices of the National
Institute on Drug Abuse in January 1987 to examine the demand-reduction potential of
mandatory treatment. Leukefeld & Tims, An Introduction to Compulsory Treatment for
Drug Abuse: Clinical Practice and Research, in NATIONAL INSTITUTE ON DRUG ABUSE,
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, NIDA MONOGRAPH No. 86, CoM-
PULSORY TREATMENT: RESEARCH AND CLINICAL PRACTICE 1-2 (1988) [HEREINAFTER NIDA
MONOGRAPH No. 86]. The strong consensus of the meeting was to reject compulsion as a
primary strategy. (The author was a member of the NIDA steering group and is reporting
his conclusions on the outcome of the meeting).
255 Coercion also runs contrary to the humanistic traditions of psychiatry. See Schot-
tenfeld, Involuntary Treatment of Substance Abuse Disorders-Impediments to Success,
52 PSYCHIATRY 164 (1989).
256 See Anglin, Brecht & Maddahian, Pre-treatment Characteristics and Treatment
Performance of Legally Coerced versus Voluntary Methadone Maintenance Admissions,
27 CRIMINOLOGY 537 (1989); Leukefeld & Tims, Compulsory Treatment: A Review of
Findings, in NIDA MONOGRAPH No. 86, supra note 254, at 236; see also Anglin, The
Efficacy of Civil Commitment in Treating Narcotic Addiction, in NIDA MONOGRAPH No.
86, supra note 254, at 31-32; Maddux, Clinical Experience with Civil Commitment, in NIDA
MONOGRAPH No. 86, supra note 254, at 35.
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Civil commitment as a form of compulsory treatment has been
legally possible in the last twenty-five years. The first state pro-
grams included the California Civil Addict Program257 and the New
York Narcotic Addiction Control Commission;258 currently
twenty-five states have civil commitment statutes in effect. The
Federal Narcotic Addict Rehabilitation Act ("NARA")259 also au-
thorizes compulsory admission for drug treatment. 60 Studies of
the effectiveness of civil commitment in the decade from 1965 to
1975, when it was actively used, demonstrate that it was at least
as effective as voluntary treatment. 261 Despite the continuing sta-
tutory authority for civil commitment, however, relatively few
drug-dependent individuals have been civilly detained and treated
since the mid-1970s 2 62
Mandatory treatment through the criminal justice system is
also authorized under numerous statutes that provide for treatment
as a condition of release on bail, probation and parole.263 While
treatment under many of these schemes is technically voluntary,
failure to agree to and carry out the treatment program can result
in incarceration. 264 Under this scheme the drug-dependent person
clearly has a vested interest in opting for treatment.
257 Anglin, The Efficacy of Civil Commitment in Treating Narcotics Addiction, 18 J.
DRUG ISSUES 527 (1988); Anglin & McGlothlin, Outcome of Narcotic Addict Treatment in
California, in NIDA MONOGRAPH No. 51, supra note 224, at 109.
78 See Inciardi, Compulsory Treatment in New York: A Brief Narrative History of
Misjudgment, Mismanagement, and Misrepresentation, 18 J. DRUG ISSUES 547 (1988);
Winick, Some Policy Implications of the New York State Civil Commitment Program, 18
J. DRUG ISSUES 561 (1988).
719 See Lindblad, Civil Commitment Under the Federal Narcotic Addict Rehabilitation
Act, 18 J. DRUG IssuEs 595 (1988).
2m For other examples of civil approaches to involuntary treatment, see Bursten, Post-
hospital Mandatory Outpatient Treatment, 143 AM. J. PSYCHIATRY 1255 (1988); Herrington,
Outpatient Commitment: A Care Option Offering Structured Therapy with Less Restriction,
PSYCHIATRIC NEWS, Feb. 7, 1986, at 7. As to the constitutionality of civil commitment,
see Rosenthal, The Constitutionality of Involuntary Civil Commitment of Opiate Addicts,
18 J. DRUG ISSUES 641 (1988).
261 See supra note 256 and accompanying text.
262 See NIDA MONOGRAPH No. 86, supra note 254; Anglin, A Social Policy Analysis
of Compulsory Treatment for Opiate Dependence: Introduction, 18 J. DRUG ISSUES 503
(1988) (introduction to volume devoted to civil commitment); W. McGLOTHL1N & M.
ANGLIN, COMPULSORY TREATMENT OF OPIATE DEPENDENCE (1988).
3 See, e.g., 18 U.S.C. § 4251 (1984).
24 Many jurisdictions direct eligible drug-dependent individuals from the criminal jus-
tice to the treatment system. Under federal law, for example, this can take place as a
condition of bail, or in lieu of a trial or sentence. 18 U.S.C. § 4251f (1984). Unfortunately,
this statute has been repealed, effective November 1, 1992. Comprehensive Crime Control
Act of 1984, Pub. L. No. 98-473, § 218, 98 Stat. 2027.
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Extensive research has been undertaken concerning the suc-
cess of mandatory treatment in the criminal justice system.265 The
criminal justice system is nearly twice as likely as any other source
to refer young users into treatment. 266 Both the TOPS267 and
DARP 268 studies show benefits to individuals under mandatory
treatment equal to, or greater than, voluntary treatment. 269
The major model for treatment in the criminal justice system is
the Treatment Alternatives to Street Crime ("TASC") program.
The goals of TASC are to identify drug users who come into
contact with the criminal justice system, to refer them to clinically
appropriate treatment, to monitor their progress, and to return
violators to the criminal justice system.270 TASC employs creative
strategies including deferred prosecution, community sentencing,
diversion to the civil treatment system, and pretrial intervention
to help funnel drug users into treatment. TASC also utilizes tra-
ditional strategies such as probation and parole supervision for
probable and proven crimes.27'
More than forty evaluations of TASC have concluded that it
has intervened effectively to reduce drug abuse and criminal ac-
tivity and that it has identified previously unrecognized drug-de-
pendent persons. 272 Indeed, researchers have concluded that crim-
inal justice treatment clients do as well or better than clients in
other drug abuse treatment programs. Successes of compulsory
treatment include significantly reduced drug use and criminal ac-
tivity, and increased employment and social coping skills.27 3 Sim-
m See generally E. WISH, M. TOBORG & J. BALLASSAI, IDENTIFYING DRUG USERS
AND MONITORING THEM DURING CONDITIONAL RELEASE: ISSUES AND PRACTICES (1988)
(because of the strong relationship between addiction and crime and the lower drug and
crime rates for persons in treatment, some researchers propose compulsory treatment); M.
STITZER & M. MCCAUL, CRIMINAL JUSTICE INTERVENTIONS WITH DRUG AND ALCOHOL
ABUSERS: THE ROLE OF COMPULSORY TREATMENT (1987) (criminal justice strategies for
treatment lack "systematic contingencies"); NIDA MONOGRAPH No. 86, supra note 254.
21 Leukefeld & Tims, supra note 256, at 239-40.
2 See supra note 226.
2 See supra note 227.
26 See supra note 256.
270 See Hubbard, Collins, Rachal & Cavanaugh, The Criminal Justice Client in Drug
Abuse Treatment, in NIDA MONOGRAPH No. 86, supra note 254, at 57 (discussing TASC
study).
27 See Cook & Weinman, Treatment Alternatives to Street Crime, in NIDA MONO-
GRAPH No. 86, supra note 254, at 99.
2TREATMENT OPTIONS, supra note 222, at 9.
27 Hubbard, Collins, Rachal & Cavanaugh, The Criminal Justice Client in Drug Abuse
Treatment, in NIDA MONOGRAPH No. 86, supra note 254, at 76. See Leukefeld & Tirs,
supra note 256, at 238
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ilarly successful outcomes are evident for correctional institution-
based treatment 274 and aftercare for probationers and parolees. 275
Compulsory treatment's proven effectiveness may persuade
even groups that are morally opposed to drug use to choose treat-
ment over punitive measures. A mandatory treatment program
could make a user's otherwise useless time in the criminal justice
system highly productive. Since a clear nexus exists between treat-
ment duration and treatment success, extended treatment in the
criminal justice system would significantly increase the probability
of a positive outcome. Despite the limits it places on personal
autonomy, compulsory treatment promises a brighter future for
drug-dependent persons than currently practiced punitive
measures.
B. Present Treatment Programs: The Gulf Between Treatment
Needs and Service Availability
Politicians 276 and public opinion polls277 alike place drug abuse
and the needle-borne spread of HIV infection among the country's
most pressing social problems. Total federal funds budgeted for
drug programs increased from $1.5 billion in Fiscal Year 1980 to
$5.669 billion in Fiscal Year 1989. For Fiscal Year 1991 the Ad-
274 H. WEXLER, A MODEL PRISON REHABILITATION PROGRAM: AN EVALUATION OF
THE "STAY'N OUT" THERAPEUTIC COMMUNITY (1988); Platt, Perry & Metzger, The Eval-
uation of a Heroin Addiction Treatment Program within a Correctional Program, in EF-
FECTIVE CORRECTIONAL TREATMENT (R. Ross & P. Gendreau eds. 1980).
27- J. BAGLIN, THE IMPACT OF THE FEDERAL DRUG AFTERCARE PROGRAM 5-6 (Federal
Judicial Center, 1986). One major study concludes that "criminal and drug use behavior,
as well as social functioning, were significantly improved during treatment for the three
groups [high, moderate and low legal coercion groups] and remained improved following
treatment. Further, the level of improvement was not related to legal coercion .... Clearly,
the beneficial impact of treatment of the measured behaviors did not differ for addicts with
legally coerced versus voluntary treatment entry." Anglin, Brecht & Maddahian, Pre-
treatment Characteristics and Treatment Performance ofLegally Coerced versus Voluntary
Methadone Maintenance Admissions, 27 CRIMINOLOGY 537, 553-54 (1989).
276 See, e.g., REPORT OF THE WHITE HOUSE CONFERENCE FOR A DRUG FREE AMERICA
(June 1988) ("Our forces are out manned, out gunned and out spent . . . . Our losses
include children born addicted, and other children recruited to crime before their teens");
THE WHITE HOUSE, NATIONAL DRUG CONTROL STRATEGY 1 (1989) ("most Americans
remain firmly convinced that drugs present the gravest present threat to our national well
being-with good reason. Because a wealth of other, up-to-date evidence suggests that our
drug problem is getting worse, not better").
27 Gallup Poll Shows Nation's Attitudes On Health Are Contradictory, BCBSA Says,
17 PENSION REP. (BNA) No. 29, at 1252 (July 16, 1990) (Drug abuse was considered the
"most important problem facing this country today" by 40% of respondents; the next highest
concerns were poverty and homelessness (9%) and the budget deficit (5%)).
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ministration proposed a total of just over $10.6 billion.278 The rise
in funding,279 the National Drug Control Strategy,280 and the tough
public talk about a "drug war"281 reflect the federal government's
social priorities. But noticeably absent from the spending, plan-
ning, and rhetoric is a comprehensive strategy for treatment and
prevention. Surprisingly, no exact government figures are kept on
the percentage of federal funds that go to treatment and prevention
as opposed to law enforcement, eradication and interdiction. But
by any account, the percentage is low. Two decades ago more
than 50% of the total drug abuse budget went to treatment and
prevention; it was reduced to between 18 and 27% during the
Reagan years in the 1980s and is approximately 29% for Fiscal
Year 1991.282
Commission and press reports have repeatedly drawn atten-
tion to the inability to meet treatment needs across the nation.28 3
States estimate that less than 12% of the more than 12 million
drug-dependent people needing treatment are actually receiving
treatment services. 284 As of September 25, 1989, 66,766 persons in
78 NATIONAL Ass'N STATE ALCOHOL AND DRUG ABUSE DIRECTORS, TREATMENT
WORKS: A REVIEW OF 15 YEARS OF RESEARCH FINDINGS ON ALCOHOL AND OTHER DRUG
ABUSE TREATMENT OPTIONS 3 (1990) [hereinafter TREATMENT WORKS].
279 See THE WHITE HOUSE, NATIONAL DRUG CONTROL STRATEGY: BUDGET SUMMARY
(1990).
21 See THE WHITE HOUSE, NATIONAL DRUG CONTROL STRATEGY (1989).
281 See Letter from President Bush to the Speaker of the House and President of the
Senate, Sept. 5, 1989, in THE WHITE HOUSE, NATIONAL DRUG CONTROL STRATEGY
("Americans' fight against epidemic illegal drug use cannot be won on any single front
alone; it must be waged everywhere-at every level of Federal, State, and local government
and by every citizen in every community across the country").
m See Brecher, Needles and the Conscience of a Nation, supra note 1, at 5-6; THE
WHITE HOUSE, NATIONAL DRUG CONTROL STRATEGY: BUDGET SUMMARY (1990) (demand
reduction represents 29% of the proposed $10.6 billion FY1991 budget). Compare the
current expenditures with those proposed in MAJORITY STAFFS OF THE SENATE JUDICIARY
COMMITTEE AND THE INTERNATIONAL NARCOTICS CONTROL CAUCUS, FIGHTING DRUG
ABUSE: A NATIONAL STRATEGY (1990) (38% of the $14.6 billion proposed total for Fiscal
Year 1991 is recommended to be earmarked for demand reduction services). Senator Daniel
Partick Moynihan argues that the Anti-Drug Abuse Act of 1988 envisions a 50-50 split on
treatment and law enforcement, but the budget provides only 26% for treatment. Pear,
Drug Policy Debate Turns to Feud Between Moynihan and Bennett, N.Y. Times, June 18,
1990, at A20, col. 4.
283 See, e.g., REPORT OF THE PRESIDENTIAL COMMISSION ON THE HIV EPIDEMIC 94-
103 (1988); Marriott, Addicts Awaiting Treatment Often Face Delays and Panic, N.Y.
Times, Jan. 10, 1990, at Al, col. 5; Pinkney, Resources Lacking in Fight to BreakAIDS-
IV Drug Link, Am. Med. News, Mar. 18, 1988, at 1, 9; Kerr, Shortage of Drug Treatment
Imperils AIDS Control, N.Y. Times, Oct. 4, 1987, at 32, col. 1.
284 TREATMENT WORKS, supra note 278, at app. I (41 states and Washington, D.C.
reported that a total of 1,407,519 persons per year are currently receiving treatment for
alcohol or drug dependency. These jurisdictions estimate that an additional 10,596,419
persons need treatment).
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forty-four states responding to a national survey were on treatment
waiting lists; one half of these people had been waiting for at least
thirty days, and in many major urban states and the District of
Columbia, between 90 and 100% of persons on the lists had waited
at least thirty days. 285 In some areas addicts can wait for six months
to a year for treatment.286 Waiting lists, moreover, may be grossly
understated because many programs are so full they do not add
people to their lists.287 Addicts on waiting lists exhibit increased
involvement in crime and less interest in entering treatment.2 8 The
absence of adequate treatment services is also evident in correc-
tional facilities. Studies indicate that the vast majority of inmates
who are seriously drug-dependent are not in treatment. 289
The relatively low percentage of expenditure on demand re-
duction, and the long waiting lists for treatment, are symbolic of
society's perception of drug-dependent people as morally blame-
worthy rather than ill and of the low value given to treatment
relative to punishment. As an expert on drug treatment programs
has written, "[t]he ultimate measure of the value of policies and
programs is not the sum of their effects minus their shortcomings,
flaws, and abuses, but rather what alternative policies and pro-
grams might be developed, which, when weighed in some balance
that is sensitive to symbols as well as costs, would be better than
that which now exists. 12 90 Expenditures on demand reduction to
bridge the gulf between services and current needs would not only
be a symbol of humanity toward a historically reviled and vulner-
2s Id. The District of Columbia, Florida, and New Jersey have 100% of the people on
their lists waiting over 30 days, while New York and Rhode Island have 90% of the people
on their lists waiting for over 30 days. A 42-city survey found that in three of four cities
there were waiting lists for drug-dependent people seeking admission to treatment, The
average wait was seven weeks. U.S. CONFERENCE OF MAYORS, THE ANTI-DRUG ABUSE
ACT OF 1986: ITS IMPACT IN CITIES ONE YEAR AFTER ENACTMENT-A 42-CITy SURVEY
1 (1987).
2" Kerr, U.S. Drug 'Crusade' is Seen as Undermining Itself, N.Y. Times, Oct. 26,
1987, at Al, col. 3.
287 Malcolm, In Making Drug Strategy No Accord on Treatment, N.Y. Times, Nov.
19, 1989, at Al, col. 1.
m Brown, Hickney, Chung, Craig & Jaffe, The Functioning of Individuals on a Drug
Abuse Treatment Waiting List, 15 AM. J. DRUG & ALCOHOL ABUSE 261 (1989) [hereinafter
Brown].
29 See J. PETERSILIA, WHICH INMATES PARTICIPATE IN PRISON TREATMENT PRO-
GRAMS? 7 (1978) (fewer than 20% of inmates needing drug rehabilitation actually participated
in a treatment program); J. PETERSILIA & P. HONIG, THE PRISON EXPERIENCE OF CARVER
CRIMINALS 32 (1980).
29 Jaffe, The Swinging Pendulum: The Treatment of Drug Abusers in America, in
HANDBOOK ON DRUG ABUSE 16 (1979).
[Vol. 26
Drug Dependency and AIDS
able population but would also be a cost-effective way to reduce
drug abuse and crime.
C. The Cost-Effectiveness of Drug Treatment
In times of economic downturn, it is argued that federal and
state governments cannot afford the cost of treatment expansion.
Federal and state policy makers legitimately may inquire whether
scarce resources should be refocused on reducing demand, rather
than supply. The questions addressed here are what results policy
makers can reasonably expect from treatment programs and the
cost of programs set on reducing the incidence of drug use and
HIV infection.
The Presidential Commission on the HIV Epidemic observed
that treatment on demand can save money as well as lives. At a
purely economic level, the Commission reported, the annual cost
of keeping a person in prison is $14,500, but as little as $3,000 is
needed for drug treatment. 291 The cost of treatment compares
favorably with the $50,000 or more lifetime cost of treating a
person with AIDS.292
Comprehensive cost/benefit analyses conducted by the
TOPS293 and Tabbush 294 studies conclude that' state level funding
of drug abuse programs is economically justified. The studies fo-
cused on reduced arrest, prosecution, and incarceration costs;
reduced loss due to property theft; reduced social costs due to an
improved labor market; and reduced medical treatment costs. The
TOPS study concluded that there was an 11-30% decline in these
indirect costs as a consequence of drug abuse treatment. The
Tabbush study found a benefit-cost ratio of 1:11.54-for every
dollar spent for effective drug treatment, $11.54 of social costs is
saved. 295
211 Estimates for drug treatment costs for IV drug users in 1987 were $3,000 (outpatient
methadone maintenance), $2,300 (outpatient drug-free) and $14,600 (non-hospital residential
drug-free). TREATMENT WORKS, supra note 278, at 25.
292 See Fox, The Cost of AIDS: Exaggeration, Entitlement, and Economics, in AIDS
AND THE HEALTH CARE SYSTEM 197 (L. Gostin, ed. 1990); Fox, Financing Health Care
for Persons with HIV Infection: Guidelines for State Action, 16 AM. J. LAW & MED. 223
(1990).
29 See supra note 226.
294 V. TABBUSH, THE EFFECTIVENESS AND EFFICIENCY OF PUBLICLY FUNDED DRUG
ABUSE TREATMENT AND PREVENTION PROGRAMS IN CALIFORNIA: A BENEFIT COST ANAL-
YSIS (1986).
29 Id. at 94.
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D. Expanding Access to Demand Reduction Services
If policy makers concur that prevention and treatment-
properly designed, funded and executed-is beneficial to the in-
dividual and is cost effective, the remaining question is how best
to reach the drug user to reduce demand. The fundamental problem
with existing treatment services is that they are often far removed
from the silent world of the illicit drug user. Virtually all treatment
services are delivered through traditional drug treatment facilities
that are separated from the mainstream health care system.
Drug treatment occurs, if at all, when a drug user himself
seeks out services, has the persistence to wait his turn on the list,
and voluntarily remains in treatment for the duration necessary to
obtain results. This system is, at best, haphazard and idiosyncratic
and, at worst, designed to perpetuate the revolving door between
drug use, needle sharing, and brief stays in detoxification or in
prison. Indeed, all the evidence points to (1) large numbers of
unrecognized cases of serious drug dependence; 296 (2) cases that
do come forward and are placed on lists where the individual
progressively loses interest in treatment;297 (3) short periods of
detoxification with few individuals logging sufficiently long stays
in treatment to make a difference; 298 and (4) repeated contacts with
emergency medical services and with the criminal justice sys-
tem.299 This pattern suggests that the current segregated treatment
system is neither capable of recruiting large numbers of drug users
nor of keeping them in treatment.
The lesson for policy makers from the social science research
is therefore relatively simple. The most effective strategy to reduce
the dual epidemics of drugs and AIDS is to identify as many
unrecognized cases as possible and to give them the opportunity
to enter and remain in treatment for durations that maximize the
chance of a positive outcome.
Two distinct foci for enhancing the capacity to identify and
treat drug-dependent persons are the health care and criminal
2 See infra notes 301, 318-322 and accompanying text.
297 See Brown, supra note 288, at 261 (51.7% of all persons on a waiting list become
less interested in entering treatment).
299 Sheffet, Quinones, Lavenhar, Doyle & Prager, An Evaluation ofDetoxification as
an Initial Step in the Treatment of Heroin, 133 AM. J. PSYCHIATRY 337 (1976) (only 9.6%
of patients admitted to a detoxification unit sought long-term treatment).
29 See infra notes 300-322 and accompanying text.
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justice systems. Large numbers of otherwise unrecognized and
untreated drug users come into contact with both systems. It
simply makes no sense to have a seriously dependent person pass
through an emergency room, hospital, courtroom, or prison and
fail to identify her as a person who needs treatment. Even if the
person is properly identified, there presently is insufficient capacity
in these settings to provide treatment or even to make a referral.
The settings are not designed or funded to provide treatment, and
the training and experience of staff is inadequate to provide expert
care for seriously drug-dependent persons. However, both the
health care and criminal justice systems could remedy these
problems.
1. The Health Care System
Seriously drug-dependent people are likely to have multiple
health problems, not only because of the physical and psycholog-
ical effects of their dependency, but because they are likely to be
poor, malnourished, even homeless. As a result of their multiple
health problems, drug-dependent persons are likely to come into
contact with the health care system in traditional venues such as
hospitals, emergency rooms, community health and mental health
centers, family physician offices, health maintenance organizations
and the like.
The number of drug related hospital admissions increased by
121% between 1985 and 1988. Included in this figure is a twenty-
eight-fold increase in hospital admissions involving smoked co-
caine (crack).300 Unidentified drug users, many already HIV-pos-
itive, pass through the health care system. Blinded studies of
sentinel hospitals throughout the United States suggest that as
many as 80,000 cases of HIV infection pass undetected through
American hospitals each year.3 1 In large urban areas up to 50%
30 THE WHITE HousE, NATIONAL DRUG CONTROL STRATEGY 3 (1989).
301 See Kelen, DiGiovanna & Bisson, Human Immunodeficiency Virus Infections in
Emergency Department Patients, 262 J. AM. MED. A. 518 (1989) (of 2544 consecutive
emergency department patients at Johns Hopkins Hospital, 152 (6%) were HIV-positive
and 95 (63%) were not previously known to be infected); Soderstrom, Furth, Glasser,
Dunning, Groseclose & Cowley, HIV Infection Rates in a Trauma Center Treating Pre-
dominately Rural Blunt Trauma Victims, 29 J. TRAUMA 1526 (1989) (1.7% of patients at
the Statewide Trauma Center in Baltimore were HIV-positive); Gordin, Givert, Hawley &
Willoghby, Prevalence of the Human Immunodeficiency Virus and Hepatitis B Virus in
Unselected Hospital Admissions: Implications for Mandatory Testing and Universal Pre-
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or more of these cases of HIV infection are likely to be among
unrecognized and untreated IV drug users. 0 2 Studies of medical
centers and emergency rooms indicate that a substantial number
of patients have recently used an illicit drug, and many may be
seriously dependent.30 3 Testing of all patients for recent drug use
would be easy enough to implement, but in the present political
and legal climate such testing would raise serious privacy con-
cerns. These concerns would not be as serious if a drug user did
not have to fear criminal prosecution.
Even if seriously drug-dependent people were identified in
traditional health care settings, they would be unlikely to receive
the expert care needed to ameliorate their long-term dependencies.
Traditional medicine is ill-prepared, at the most fundamental lev-
els, to provide effective drug abuse treatment. Research shows
that medical school training in the area of drug abuse is quite poor.
Although it is improving, the number of qualified instructors, spe-
cific courses, time spent in the curriculum and contact with drug-
dependent clients generally is low.304 The rest of medical educa-
tion, from internship through residency, rarely exposes students
to addicts and the problems of drug dependency.305 Even primary
cautions, 161 1. INFECTIoUs DISEASES 14 (1990). In the CDC sentinel hospital study the
HIV prevalence rate ranged from 0.1 to 7.6%. Counseling and Testing for HIV Infection
in Acute Care Hospitals, CDC Strategic Planning Meeting (April 5-6, 1990); St. Louis,
Rauch, Petersen, Anderson & Domdero, Seroprevalence Rates of Human Immunodefi-
ciency Virus Infection at Sentinel Hospitals in the United States, 323 N. ENO. J. MED. 213
(1990).
3 See supra note 12 and accompanying text.
303 See Lindenbaum, Carroll, Daskal & Kapusnick, Patterns of Alcohol and Drug
Abuse in an Urban Trauma Center: The Increasing Role of Cocaine Abuse, 29 J. TRAUMA
1654 (1989) (74% tested positive for illicit or prescription drugs in their blood, including
cocaine (54.4%), cannabinoids (37.2%), barbiturates (7.1%), amphetamines (4.7%) and
opiates (9%)); Marzuk, Tardiff, Leon, Stajic, Morgan & Mann, Prevalence of Recent
Cocaine Use Among Motor Vehicle Fatalities in New York City, 263 J. A.M.A. 250 (1990)
(18.2% of both drivers and passengers tested positive for cocaine use); Bailey, Cocaine
Detection During Toxicology Screening of a University Medical Center Patient Population,
25 J. CLINICAL ToxICOLOGY 71 (1987) (10% tested positive for cocaine).
30' Bigby, Substance Abuse Education During Internal Medicine Training, 74 J. GEN.
INTERNAL MED. 74 (1989); Confusione, Jaffe & Rosen, Drug Abuse*Training as Part of a
Family Medicine Clerkship, 57 J. MED. EDUc. 409 (1982); Fassler, Views of Medical
Students and Residents on Education in Alcohol and Drug Abuse, 60 J. MED. EDUC. 562
(1985); Glass, Substance Abuse and Professional Education: A Tops-down or Bottoms-up
Approach, 83 BRIT. J. ADDICTION 999 (1988); Helwick, Substance Abuse Education in
Medical School: Past, Present, and Future, 60 J. MED. EDuc. 707 (1985); see also Pokorny
& Solomon, A Follow-up Survey of Drug Abuse and Alcoholism Teaching in Medical
Schools, 58 J. MED. EDUC. 316 (1983).
3- Coulehan, Zettler-Segal, Block, McClelland & Schulberg, Recognition of Alcohol-
ism and Substance Abuse in Primary Care Patients, 147 ARCH. INTERN. MED. 349 (1987);
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care physicians themselves feel they are incompetent to treat sub-
stance abuse.306 The beliefs of physicians are confirmed by studies
showing pitifully low levels of accuracy in identifying and diag-
nosing substance abuse.307 Even when substance abuse is recog-
nized, it is the health care problem most likely to be referred
outside the primary care physician's practice. 30 8 Physicians have
had little reason to study substance abuse since addicts are either
shipped off to prison or never identified. It is likely that if public
health objectives prevailed, medicine would quickly respond with
better education and more active practice.
Current medical school students may possess the same kinds
of biases against substance abusers as the general population.
Their perception of the "skid row individual with a poor social
and medical prognosis" only grows deeper during medical educa-
tion.30 9 Medical training to dispel these myths and improve treat-
ment skills has been wholly inadequate. 310 Even if attitudes toward
drug-dependent persons in the general population do not change,
medical schools would do well to change the tenor in the
classroom.
The inadequate medical education, and the poor attitudes to-
ward drug users among physicians, are not the only problems in
providing drug treatment services in the mainstream health care
see also Galanter, Subspecialty Training in Alcoholism and Drug Abuse, 146 AM. J.
PSYCHIATRY 8 (1989); Galanter, Kaufman, Taintor, Robinowitz, Meyer & Halikas, The
Current Status of Psychiatric Education in Alcoholism and Drug Abuse, 146 AM. J. Psy-
CHIATRY 35 (1989); Taliaferro, Rund, Brown, Goldfrank, Jorden, Ling & Gallery, Substance
Abuse Education in Residency Training Programs in Emergency Medicine, 18 ANN. EMER-
GENCY MED. 1344 (1989).
3 Kennedy, Chemical Dependency: A Treatable Disease, 81 OHIO ST. MED. J. 77
(1985) (71% of physicians felt either incompetent or ambivalent about treating alcoholism);
Fassler, Views of Medical Students and Residents on Education in Alcohol and Drug
Abuse, 60 J. MED. EDUC. 562 (1985) (28% felt incompetent to treat alcoholism).
"7 Lewis & Gordon, Alcoholism and the General Hospital: The Roger Williams Inter-
vention Program, 59 BULL. N.Y. ACAD. MED. 181 (1983) (although substance abuse is
evident in 20-50% of general hospital admissions, it is diagnosed in fewer than 5% of
admissions).
3 See generally Gottlieb, Mullen & McAlister, Patients' Substance Abuse and the
Primary Care Physician: Patterns of Practice, 12 ADDICTIVE BEHAV. 23 (1987).
3w Lewis, Niven, Czechowicz & Trumble, A Review of Medical Education in Alcohol
and Other Drug Abuse, 257 J. A.M.A. 2945 (1987).
310 Committee on Adolescence, American Academy of Pediatrics, The Role of the
Pediatrician in Substance Abuse Counseling, 72 PEDIATRICS 251 (1983); Health and Public
Policy Committee, American College of Physicians, Chemical Dependence, 102 ANNALS
INTERN. MED. 405 (1985). Model programs are under way to try to correct the problems
in medical education. See Lewis, Niven, Czechowicz, & Trumble, supra note 309, at 2947
(discussing NIAAA and NIDA conferences and model programs for physician training in
substance abuse).
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system.311 Physicians in most mainstream health care settings can-
not legally prescribe methadone-the FDA approved chemical
treatment for opiate abuse. 312 Prescribing methadone has, from its
discovery and approval, been highly regulated. There are strict
conditions for the use of methadone by which all health care
providers must abide. 3 3 In particular, a provider cannot prescribe
methadone unless she is specifically approved for the purpose, and
approval is not granted unless there is compliance with detailed
regulations concerning staff-patient ratios, counseling, and paper-
work. The objective of the regulations is to ensure in-depth psy-
chological and medical care and counseling so that methadone
maintenance centers are not mere "watering holes" to continue
addiction. However, the regulations have had the effects of
(1) stifling the growth of methadone maintenance programs be-
cause of the inordinate costs in complying with the regulations;
and (2) discouraging ordinary health care providers from offering
drug abuse treatment at all. Consider the typical case where a
seriously dependent person is in an emergency room or is an in-
patient in a city hospital. The provider can treat all of the physical
conditions associated with drug use, but is unable to prescribe
anything related to the primary diagnosis of drug dependency. The
provider's only realistic option is to place the patient on a waiting
list for a separate drug treatment slot, with all of the known limi-
tations of a waiting list placement. 314
The Department of Health and Human Services has already
issued proposed rules to try to ease the regulatory burden on
methadone maintenance programs in response to the HIV epi-
demic. 315 The proposed rules authorize minimum service mainte-
nance therapy to patients awaiting comprehensive maintenance
treatment, and require counseling on the avoidance of HIV trans-
mission. Professionals providing minimum service maintenance
treatment are required to provide a medical examination and ser-
311 See generally Evans, Accessing Intravenous Drug Users via the Health Care Sys-
tem, in NATIONAL INSTITUTE ON DRUG ABUSE, U.S. DEPARTMENT OF HEALTH AND
HUMAN SERVICES, NIDA MONOGRAPH No. 93, AIDS AND INTRAVENOUS DRUG USE:
FUTURE DIRECTIONS FOR COMMUNITY-BASED PREVENTION RESEARCH 277 (1990).
312 See supra notes 239-253 and accompanying text.
313 21 C.F.R. § 291 (1990) (the Methadone Regulation).
324 See supra notes 218-220 and accompanying text.
315 Dep't of Health & Human Services, FDA, & NIDA, Methadone in Maintenance
and Detoxification: Joint Revision of Conditions for Use, 54 (40) Fed. Reg. 8954 (1989) (to
be codified at 21 C.F.R. § 291).
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vices, but not rehabilitative services and routine urine screening.
These are regarded as interim measures only until the client can
be transferred to a comprehensive program. 316
Thus, although both drug-dependent people and physicians
believe that drug treatment services should be more fully inte-
grated into the health care system, and although the health care
system has the unique capacity to identify and care for patients,
there remain systematic problems in utilizing the mainstream
health care system for these purposes. Integration of drug treat-
ment into primary care, hospitals, community health and mental
health centers, health maintenance organizations and other pro-
viders will require a sizable influx of resources for training, facil-
ities, and staff. It will also require fundamental reform of federal
regulations to allow physicians to prescribe methadone and future
chemical treatments much in the same way that they can currently
prescribe in other areas of medicine.
2. Criminal Justice System
Drug abuse is placing an extraordinary strain on law enforce-
ment, courts, and prisons. 317 Considerable evidence exists showing
the close relationship between drug use and crime. The Drug Use
Forecasting (DUF) program of the National Institute of Justice
monitors drug use among recently arrested persons in selected
cities. DUF staff obtain voluntary, anonymous urine specimens
from a sample of male arrestees from twenty-two cities. The prev-
alence of recent cocaine use (at least 50%) among arrestees is
striking. This figure is, moreover, an underestimate since DUF
significantly limits the participation in its studies of persons who
are arrested on charges of possession or sale of drugs. 318 The
finding that at least 20% of drug injectors in this study reported
sharing needles indicates that there is a continuing risk for the
316 1d. at 8973-74.
317 See generally U.S. GENERAL ACCOUNTING OFFICE, GAO/GG 88-39, CONTROLLING
DRUG ABUSE: A STATUS REPORT, SPECIAL REPORT FROM THE COMPTROLLER OF THE
UNITED STATES (1988).
318 Centers for Disease Control, Urine Testing for Drug Use Among Male Arrestees-
United States 1989, 38 MOR1IDITY & MORTALITY WEEKLY REP. 780 (1989). Urine tests
were positive for cocaine most commonly in New York (76%), Philadelphia (74%), and the
District of Columbia (65%), and least likely in the smaller cities of Indianapolis (26%) and
San Antonio (24%). See also National Institute of Justice, DUF: Drug Use Forecasting
(1989) (the incidence of cocaine use tripled in two years).
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spread of HIV and other blood-borne infections. 319 Between 75
and 83% of persons incarcerated reported they had used drugs in
the past, and between one-third and two-fifths reported they were
under the influence of an illegal drug at the time of the offense. 31
Many prisoners even take drugs after they are incarcerated
and often share injection equipment with other prisoners. 321 One
rural prison system reported that 26.9% of the inmate samples
tested positive for illicit drugs. While the prison system was able
to lower this rate to 9.2% with routine drug screening and punish-
ments, it indicates that drug use among incarcerated inmates can
be substantial. 322
Despite the large number of drug-dependent persons coming
into contact with the criminal justice system, there are few com-
prehensive, treatment programs. One national survey found that
only four percent of state prison inmates received any treatment,
and almost half the nation's state prisons were not served by any
identifiable drug abuse treatment program. 323 For many in the
criminal justice system, routine urine testing is the only "treat-
ment" provided. 324 The criminal justice system, particularly in
corrections, often presents ideological, economic and practical
reasons for not providing treatment for more people. This resis-
tance to establishing effective drug treatment programs reflects
once again the tension between the preventive and punitive goals
of criminal justice and rehabilitation. Even if this conflict could be
resolved, it is argued that severe prison overcrowding and the
strain on resources make the provision of effective treatment very
difficult.
The ideological aversion to rehabilitation is not a serious ar-
gument against sufficient and adequate treatment in the corrections
319 Centers for Disease Control, supra note 318, at 783. The incidence of opiate use
was considerably less than cocaine use. In 9 out of 14 cities less than 10% of arrestees
tested positive for opiates. See also NATIONAL INSTITUTE OF JUSTICE, supra note 318.
320 U.S. DEPARTMENT OF JUSTICE, OFFICE OF JUSTICE PROGRAMS, BUREAU OF JUSTICE
STATISTICS, DRUGS AND CRIME FACTS, 1989, at 5 (1989).
321 See Carvell & Hart, Risk Behaviours for HIV Infection Among Drug Users in
Prison, 300 BRIT. MED. J. 1383 (1990).
322 Vigdal & Stadler, Controlling Inmate Drug Use Cut Consumption by Reducing
Demand, CORRECTIONS TODAY, June 1990, at 96. This study took place in the Wisconsin
prison system. The number of inmates using drugs in urban prison systems is likely to be
higher.
323 F. TIMs, DRUG ABUSE TREATMENT IN PRISONS 13 (National Institute on Drug
Abuse, Research Report No. ADM 86-1149, 1981, reprinted 1986).
324 See Drug Testing: Drug Testing Common, Often Random, in INSTITUTIONS, PRO-
BATION AND PAROLE CORRECTIONS COMPENDIUM 12 (Aug. 1986).
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system. Rather, it is a mere abstraction fueled by the government's
policy of holding users accountable or punishing them. To be sure,
there are budgetary and practical constraints on treatment expan-
sion in prisons. However, financial analyses continually show that
treatment is highly cost effective. 325 Planners should carefully con-
sider the future savings associated with effective treatment when
attempting to work within present budgetary constraints.
Systematic and, if necessary, compulsory treatment of per-
sons in the criminal justice system is fully consistent with the
research presented earlier.326 Criminal justice system settings (such
as diversion, probation, prison and parole) provide optimal oppor-
tunities for treatment: large numbers of drug users come into
contact with these programs; they are captive participants who
otherwise have unproductive time; they are already subject to state
control because of their offenses so that the same level of consti-
tutional concerns raised by civil commitment or health system
testing are not presented; and they may remain under control for
considerable periods, thereby providing the best opportunity for
successful treatment outcomes.
The National Treatment Alternative to Street Crimes (TASC)
program has already shown that a demand reduction model works
better, is more humane, and costs less than the model of punish-
ment and retribution that has dominated government thinking for
the last decade and more. Furthermore, making a real commitment
to treatment might help ease present constitutional and civil rights
concerns that limit the justice system's attempts to identify drug
users.
Conclusion
The lesson learned more than a half-century ago in the mid-
winter epidemic of malaria, and now in the cocaine-ravaged inner
cities of America, is that drug use and the needle-borne spread of
infection are primarily public health problems. Seriously drug-
dependent people are neither uncaring about the affects of drug
use and AIDS on themselves or their partners, nor are they unable
to change their behaviors if given the education, means, and ser-
"1 See supra notes 293-295 and accompanying text.
326 See supra notes 254-275 and accompanying text.
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vices to do so. They are more ill, than bad, human beings, and
mostly unable to escape from their physical dependencies by ad-
monitions to "just say no" or draconian criminal penalties. Social
science research has provided a clear agenda for confronting the
dual epidemics of drug dependence and AIDS, if the national will
and resources are devoted to achieving this end.
